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Abstract 
Complementary short interfering RNAs (siRNAs) are routinely used to knockdown gene 
expression.  siRNAs bind to their target sequence and guide transcript cleavage and subsequent 
degradation.  This type of silencing is associated with equivalent levels of RNA and protein 
knockdown.  siRNA-mediated knockdown was originally thought to be highly specific.  
However, the downregulation of non-target mRNAs has been observed following transfection of 
siRNAs in human cells.  Many of these RNA changes are due to siRNA binding to partially 
complementary sequences within nontargeted transcripts and therefore are termed “off-target” 
effects.   
To examine the mRNA:siRNA interactions important for off-target effects, we generated 
a panel of mRNA:siRNA combinations containing a variety of base pairing interactions in the 9th, 
10th, and 11th positions of two siRNA binding sites located in a reporter gene.  This region was 
chosen because siRNA-mediated transcript cleavage occurs between the 10th and 11th positions of 
the mRNA:siRNA duplex.  Approximately half of the mRNA:siRNA combinations containing 
mismatches in positions 9-11 resulted in a two-fold or more mRNA decrease, with varying 
degrees of protein knockdown.  mRNA and protein analysis revealed combinations for which the 
resulting mRNA and protein levels did not correlate.  Although siRNA-mediated transcript 
cleavage is catalyzed by the endonuclease Argonaute 2 (Ago2), knockdown of Ago2 expression 
did not affect mRNA knockdown for imperfectly complementary combinations.  These results 
indicate that off-target mRNA reductions are likely attributable to Ago2-independent degradation 
processes. 
Using the same reporter system we have also uncovered instances in which 
complementary siRNAs resulted in high protein/RNA knockdown ratios with dramatic protein 
silencing.  For these particular combinations, the disparity between RNA and protein knockdown 
is dependent on Ago2 function.  This may suggest that the sequences within atypical 
complementary mRNA:siRNA combinations result in unproductive cleavage by Ago2, leading to 
persistent binding and enhanced silencing through translational repression.  
Our findings demonstrate that differences within complementary target sequences can 
lead to differences in the type of silencing mechanisms that result.  The results presented in this 
dissertation also provide a better understanding of how off-target effects mediate mRNA and 
protein knockdown of unrelated transcripts, with meaningful implications for those using siRNAs 
as a tool.  
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Introduction to small RNA-mediated silencing 
Development and proper cell function rely on the precise temporal and spatial 
control of gene expression, which is accomplished by the exquisite regulation of the 
genes involved in these processes.  Regulation of gene expression can be highly 
complex, often involving both proteins and noncoding regulatory RNAs that work in 
conjunction to repress or activate gene expression.  Noncoding RNAs have been 
implicated in an array of regulatory functions including chromosome structure, DNA 
replication, splicing, rRNA processing, RNA editing, ribosome function, and protein 
sorting.  More recently, the understanding of the regulatory roles of noncoding RNAs in 
gene expression has been broadened by the discovery of RNA interference (RNAi).  
RNAi is a conserved cellular silencing response triggered by double stranded RNA 
(dsRNA).  dsRNA molecules are processed by the RNAi machinery into small silencing 
RNAs (siRNAs), which guide the silencing of complementary sequences (Elbashir et al., 
2001b; Voinnet and Baulcombe, 1997; Zamore et al., 2000).  The discovery of RNAi has 
enabled the identification of a new class of noncoding RNAs with critical roles in the 
regulation of gene expression, broadly known as small RNAs.  This new class of 
noncoding RNAs has been found to regulate gene expression at many different levels in 
nearly every model eukaryotic organism. 
RNAi was first observed in plants.  Introduction of a transgene homologous to the 
chalcone synthase (CHS) enzyme in petunias, led to silencing of both the transgene and 
the endogenous CHS gene (Napoli et al., 1990).  The discovery of RNAi arose from 
observations in Caenorhabditis elegans (Fire et al., 1998).  Injection of dsRNA with 
sequence complementary to an endogenous gene led to its specific silencing. 
Subsequently, RNAi and RNAi-related mechanisms have been reported in a variety of 
organisms, including trypanosomes, planaria, fungi, flies, zebrafish, mice and humans.  
Chapter 1: Introduction 
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It is thought that RNAi might have arisen as a defense mechanism against foreign 
nucleic acid elements, such as viruses and transposons, whose propagation and 
replication often involve a dsRNA molecule.  In plants and C. elegans, RNAi signals can 
be transmitted between cells and through the germ line, making this a potent immune 
response in these organisms.   
In addition to its role as a defense mechanism against foreign nucleic acid 
elements, the RNAi machinery has also been implicated in the biogenesis and function 
of an endogenous small RNA subclass, now known as microRNAs (miRNAs), which 
naturally forms dsRNA hairpins.  miRNAs were first identified by Victor Ambros and 
colleagues in C. elegans prior to the discovery of RNAi (Lee et al., 1993).  The C. 
elegans miRNA lin-4 was shown to negatively regulate the temporal expression of the 
lin-14 protein through the first larval stage (Wightman et al., 1993).  Components of the 
RNAi pathway responsible for the processing of dsRNA precursor into siRNAs, were 
also found to process hairpin miRNA precursors, thereby providing roles for the RNAi 
machinery in an endogenous regulatory mechanism (Grishok et al., 2001).  The 
realization that the biogenesis of siRNAs and miRNAs is connected has led to the 
discovery many more miRNAs.  miRNAs have been uncovered in plants and animals, 
where they serve to regulate developmental transitions and basic cell processes by 
suppressing expression of key transcripts.   
The discovery of RNAi has also resulted in the intense study of the RNAi 
pathway components that mediate the biogenesis and function of small RNAs. Among 
the most important of these factors are Argonaute proteins.  Small RNAs bind to one or 
more Argonaute proteins.  The type of small RNA and the specific Argonaute protein it 
binds to, determine the type of biological regulation these small RNAs mediate.  
In addition to siRNA and miRNAs, new classes of small silencing RNAs have 
been uncovered. Moreover, small silencing RNAs have been implicated in a broad array 
Chapter 1: Introduction 
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of cellular processes.  For example, small RNAs derived from genomic repeat regions 
called heterochromatic small RNAs (hcRNAs), have been identified in Saccharomyces 
pombe, Trypanosoma brucei and plants, where their function is associated with 
transcriptional silencing of heterochromatic regions.  scanRNAs (scnRNAs) have been 
identified in Tetrahymena thermophila, where they participate in chromatin modification 
and DNA elimination during differentiation.  More recently, a new class of small silencing 
RNAs, Piwi-interacting RNAs (piRNAs) has been implicated in transposon silencing in 
the germline of flies and mammals.   
Mammalian small RNAs can be broadly divided into three subclasses: siRNAs, 
miRNAs and piRNAs.  This chapter will focus on the subclasses of small mammalian 
silencing RNAs relevant for this work: siRNAs and miRNAs.  In addition, emphasis will 
be placed on discussing the mammalian Argonaute proteins that mediate siRNA and 
miRNA biology.  
siRNAs 
Introduction to siRNAs 
siRNAs are 21-23 nucleotide dsRNA molecules with 3' two nucleotide hydroxyl 
overhangs and 5' monophosphates.  siRNAs were originally found to be associated with 
transgene silencing in plants (Hamilton and Baulcombe, 1999).  Using Drosophila 
extracts, two different studies demonstrated that siRNAs are the effector molecules of 
RNAi (Hammond et al., 2000; Zamore et al., 2000).  Subsequent experiments showed 
that chemically synthesized siRNAs could be used in mammalian cells to silence the 
expression of transfected reporters and endogenous genes (Elbashir et al., 2001a).  
siRNA biogenesis 
siRNAs originate from long double stranded precursors that are cleaved 
Chapter 1: Introduction 
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processively by the RNAse III enzyme Dicer (Hammond et al., 2000), Figure 1.1).  
Dicer’s endonuclease activity cleaves a long double stranded RNA molecule (dsRNA) at 
21 nucleotide intervals (Elbashir et al., 2001b; Elbashir et al., 2001c; Zamore et al., 
2000).  Dicer enzymes do not act alone.  In C. elegans, Drosophila, and mammals, Dicer 
proteins form a complex with dsRNA binding protein partners and this binding is 
generally required for Dicer’s function (reviewed in Rossi, 2005).  In mammals, Dicer 
binds to the TAR DNA-binding protein (TRBP) (Chendrimada et al., 2005; Haase et al., 
2005). 
siRNAs regulate gene expression by binding to the RNA induced silencing 
complex (RISC) and mediating mRNA degradation of complementary targets (Figure 
1.1).  Only one strand of the siRNA duplex, the guide strand, is incorporated into RISC.  
siRNA strand selection is accomplished by cleavage of the non-incorporated strand 
(termed the passenger strand).  Cleavage of the passenger strand is accomplished 
through the action of the catalytic core of the RISC complex, a member of the conserved 
Argonaute family (Kiriakidou et al., 2007; Leuschner et al., 2006; Matranga et al., 2005; 
Rand et al., 2005).  Humans have four Argonaute proteins (Argonautes 1-4), however, 
only Argonaute 2 (Ago2) has been shown to have catalytic activity in vitro (Liu et al., 
2004; Meister et al., 2004) (the Argonaute family will be discussed in greater detail in 
later sections).  In mammals, Ago2 is responsible for passenger strand cleavage 
(Leuschner et al., 2006; Matranga et al., 2005).  Which of the two strands is incorporated 
and which strand is cleaved depends on the relative thermodynamic stability of the 
strands’ 5' ends.  The strand within the less thermodynamically stable or less tightly 
paired 5' end is incorporated into RISC (Khvorova et al., 2003; Leuschner et al., 2006; 
Schwarz et al., 2003).  This observation has enabled the establishment of more efficient 
siRNA design guidelines for experimental and therapeutic applications.   
RISC was first identified by co-immunoprecipitation with a biotinylated siRNA 
Chapter 1: Introduction 
 15 
(Martinez et al., 2002).  RISC activity has been associated with complexes of various 
sizes, ranging from 160 kDa to 80S (Gregory et al., 2005; Martinez et al., 2002; 
Mourelatos et al., 2002; Nykanen et al., 2001; Pham et al., 2004).  All of these RISC 
complexes bind a member of the Argonaute family.  In mammalian cells, RISC binds 
Ago2.  Although recombinant Ago2 alone, charged with a single stranded siRNA 
(ssRNA), can induce silencing of a target transcript (Rivas et al., 2005), it cannot use 
dsRNA as a substrate, indicating that other components of RISC are essential for its 
activity in vivo (Liu et al., 2004).  Subsequent studies have identified a 500 kDa RISC 
complex that can use both ssRNA and dsRNA as substrates (Gregory et al., 2005).  The 
500 kDa RISC complex is composed of Dicer, TRBP, and Ago2.  In mammalian cells, 
both Dicer and its double stranded RNA binding partner, TRBP, are needed for efficient 
dsRNA processing (Chendrimada et al., 2005; Haase et al., 2005).  Therefore, it appears 
that both siRNA processing and function are linked by a common set of proteins. 
siRNA-mediated regulation and function 
The mechanism responsible for siRNA-mediated silencing has been carefully 
studied.  Conventionally, siRNAs are known to bind transcripts containing perfect 
complementary sequences.  This results in endonucleolytic cleavage by Ago2 on the 
target between the bases paired with positions 10 and 11 of the guide strand (Elbashir et 
al., 2001b), Figure 1.1).  The guide strand remains associated with RISC, allowing it to 
perform multiple rounds of cleavage.  This cleavage event leads to target mRNA 
degradation and, as a consequence, inhibition of protein synthesis.  Therefore, siRNA 
targeting is associated with the same degree of RNA and protein knockdown.  
Endogenous siRNAs have been identified in fungi, plants and C. elegans.  
Naturally occurring sources of dsRNA in these organisms include convergent 
transcription, transcription of repetitive elements or transposons, and viral replication 
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intermediates (reviewed in Farazi et al., 2008).  Endogenous siRNAs have been more 
extensively studied in plants, where they originate from overlapping sense and antisense 
transcripts (natural antisense transgenes or natsiRNAs) or from non-coding genomic and 
repeat-associated regions (transacting siRNAs or tasiRNAs and hcRNAs).  Endogenous 
siRNAs function in plants is associated with transposon and transgene silencing.   
Originally, flies and mammals were not thought to encode endogenous siRNAs. 
However, recently, extensive sequencing of Drosophila somatic cells and Drosophila 
and mouse ovaries has uncovered small noncoding RNAs with the hallmark properties 
of siRNAs (Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008; Okamura et 
al., 2008; Tam et al., 2008; Watanabe et al., 2008).  Endogenous Drosophila and 
mammalian siRNAs are 21 nucleotides long and their biogenesis seems to depend on 
Dicer and Ago2 function (Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 
2008; Okamura et al., 2008; Tam et al., 2008; Watanabe et al., 2008).  Similar to 
endogenous siRNAs in fungi, plants and C. elegans, these siRNAs are homologous to 
transposons and protein coding genes.  In Drosophila cells, mutations in the specific 
Dicer and Argonaute genes, which are largely responsible for the biogenesis of 
endogenous siRNAs, Dicer-2 and Ago2, resulted in increased expression of certain 
transposons indicating a potential function for endogenous siRNAs in animals (Ghildiyal 
et al., 2008; Kawamura et al., 2008).  However, further experiments are needed to clarify 
the role of these newly identified endogenous animal siRNAs. 
A major difference between RNAi in fungi, plants and C. elegans versus RNAi in 
flies and mammals is the presence of a siRNA-amplification step catalyzed by the RNA-
dependent RNA polymerase (RdRP) (Farazi et al., 2008).  Primary siRNAs initiate the 
formation of dsRNAs by mediating cleavage of target mRNAs, which can serve as 
substrates for RdRP activity.  Newly generated dsRNAs are cleaved by Dicer, 
generating secondary siRNAs and resulting in the amplification of the RNAi response 
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and robust silencing.  Unlike fungi, plants, and C. elegans, Drosophila and mammals, do 
not encode a RdRP enzyme within their genomes.  RdRP activity correlates with the 
ability that plants and C. elegans have of transmitting the silencing response to other 
tissues, and to the germ line.  As expected by the absence of a RdRP enzyme in flies 
and mammals, neither horizontal nor vertical RNAi transmission has been observed in 
these biological systems. 
miRNAs 
Introduction to miRNAs 
miRNAs are small RNAs transcribed from endogenous genes.  They are typically 
20-23 nucleotides long and bear similarity to siRNAs, as they also possess 5' 
monophosphates and 3' two nucleotide hydroxyl overhangs.  However, unlike siRNAs, 
which are primarily derived from long dsRNA molecules, miRNAs are processed from 
dsRNA hairpin precursors (Figure 1.1).  The first miRNA, lin-4, was discovered in C. 
elegans.  Lin-4 is required for proper developmental timing (Chalfie et al., 1981).  
Cloning of lin-4 revealed that this gene encodes a 21 nucleotide noncoding RNA (Lee et 
al., 1993).  Furthermore, lin-4 was complementary to sequences within the 3' UTR of the 
lin-14 transcript, and was found to negatively regulate the levels of the lin-14 protein 
(Wightman et al., 1993).  Subsequently, another gene involved in developmental timing 
in C. elegans, let-7, was also identified and shown to encode a small noncoding 21 
nucleotide RNA (Reinhart et al., 2000).  Similarly to lin-4, let-7 was complementary to 
elements within the 3' UTR of several genes involved in developmental timing. 
Evidence that this new class of small RNAs, subsequently termed miRNAs, might 
be related to siRNAs was provided by two key observations.  First, C. elegans Dicer 
mutants had similar phenotypes to those of lin-4 and let-7 mutants.  Second, RNAi 
components in C. elegans, in particular Dicer-1 and the Argonaute proteins, Alg-1 and 
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Alg-2, were necessary for the maturation and function of lin-4 and let-7 miRNAs (Grishok 
et al., 2001). 
miRNAs are found in the genomes of plants, animals and even viruses (reviewed 
in Matranga and Zamore, 2007) and are the most abundant class of small silencing 
RNAs in mammals.  To date, hundreds of miRNAs have been cloned and sequenced in 
various organisms.  One to two hundred miRNAs are expressed in invertebrates and 
plants (reviewed in Farazi et al., 2008).  Humans have approximately 500 miRNAs which 
are differentially expressed in tissues and throughout development (Ason et al., 2006; 
Landgraf et al., 2007).  Although miRNAs were previously thought to be expressed only 
in multicellular organisms, they have also been found in the unicellular green algae 
Chlamydomonas reinhardtii (Molnar et al., 2007; Zhao et al., 2007).  Several reports 
indicate that miRNAs regulate a wide range of cellular processes and developmental 
transitions through inhibition of protein synthesis and mRNA stability (reviewed in 
Bushati and Cohen, 2007).  In addition, alterations in miRNA expression have been 
associated with different types of cancers (reviewed in Osada and Takahashi, 2007; 
Zhao and Srivastava, 2007), and deletion of proteins involved in miRNA biogenesis has 
been associated with several diseases, such as DiGeorge syndrome (Gregory et al., 
2004). 
miRNA biogenesis 
miRNAs are encoded within non-coding protein regions or within the introns of 
protein coding genes (reviewed in Bartel, 2004).  miRNA primary transcripts (pri-
miRNAs) are transcribed by Polymerase II, sometimes as polycistronic transcripts, and 
contain both a 5' cap and a poly A tail (Tanzer and Stadler, 2004, Figure 1.1).  pri-
miRNAs, fold into imperfect double stranded hairpin structures (Figure 1.1).  pri-miRNAs 
are subsequently processed in two steps by two different RNAse III endonucleases: 
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Drosha in the nucleus and Dicer in the cytoplasm (reviewed in Kim, 2005, Figure 1.1).  In 
the nucleus, Drosha and its double stranded RNA binding partner, DiGeorge syndrome 
critical region 8 (DGCR8, also known as Pasha in Drosophila) cleave pri-miRNAs into 
approximately 70 nucleotide hairpins known as pre-miRNAs (Denli et al., 2004; Gregory 
et al., 2004; Landthaler et al., 2004; Lee et al., 2003).  Splicing of certain introns 
encoding miRNAs, generates a splicing intermediate that corresponds precisely to a pre-
miRNA, mimicking a Drosha/DGCR8 product.  These types of miRNAs are known as 
mirtrons and are able to circumvent the requirement for Drosha/DGCR8 processing 
(Berezikov et al., 2007; Okamura et al., 2007; Ruby et al., 2007). 
pre-miRNAs exit the nucleus through their interaction with Exportin 5, which 
recognizes 3' two nucleotide overhangs (Bohnsack et al., 2004; Lund et al., 2004; Yi et 
al., 2003).  Once in the cytoplasm, pre-miRNAs are processed by Dicer and its partner 
TRBP (Chendrimada et al., 2005; Haase et al., 2005).  The result is a 21-23 nucleotide 
duplex (Figure 1.1).  miRNAs bind a RNA silencing complex which is less well-defined 
than RISC.  In mammals, this complex contains one of the four human Argonaute 
proteins and is known as the microRNP (miRNP) or the miRNA-induced silencing 
complex (miRISC).  Other protein components have also been found to associate with 
miRISC.  These include the Fragile X mental retardation protein (FMRP), a modulator of 
translation in neurons, and two processing body (P-body) proteins that have been shown 
to have important roles in miRNA-mediated silencing, GW182 (named for the presence 
of glycine(G)-tryptophan(W) repeats and for its molecular mass of 182 kDa) and DEAD-
box RNA helicase RCK/p54 (reviewed in Rana, 2007).  However, exactly how all of the 
miRNP associated proteins influence miRNP function is not completely understood. 
As observed with siRNA duplexes, miRNA duplexes undergo strand selection 
which is also determined by the relative thermodynamic stability of the strands’ 5' ends 
(Khvorova et al., 2003; Leuschner et al., 2006; Schwarz et al., 2003, Figure 1.1).  The 
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strand with the less stable 5' end is simply known as the miRNA strand and the strand 
with the more stable 5' end is known as the miRNA* strand.  Unlike siRNAs, however, 
animal miRNA duplexes often contain central mismatches.  Mismatches within the 
center of small silencing RNA duplexes, whether these duplexes are siRNAs or miRNAs, 
disrupt Ago2 mediated cleavage of the strand with the more thermodynamically stable 5' 
end (Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 
2005).  As a consequence, most mature miRNA strands in animals are selected through 
a cleavage independent mechanism which is not currently well understood. 
miRNA function and target recognition 
In mammals, miRNAs repress gene expression primarily by affecting protein 
production, commonly referred to as translational repression.  Similar to siRNAs, 
miRNAs can mediate endonucleolytic cleavage of target transcripts when bound with 
perfect or near perfect complementarity (Hutvagner and Zamore, 2002; Meister et al., 
2004; Okamura et al., 2004; Yekta et al., 2004; Zeng et al., 2003, Figure 1.1).  However, 
this mode of regulation is most prevalent among plants miRNAs, because the majority of 
mammalian miRNA target sites are only partially complementary to the respective 
miRNA and therefore they do not elicit endonucleolytic cleavage.  Conversely, siRNAs 
can repress transcript expression through translational repression without 
endonucleolytic cleavage of a mRNA bearing imperfectly complementary binding sites 
(Doench et al., 2003; Zeng et al., 2003). These observations indicate that the extent of 
complementarity between a small silencing RNA and its target (and not its origin) 
determines whether the small RNA mediates cleavage or translational repression.  
Translational repression is mediated through the action of an Argonaute protein within 
the miRNP.  All four human Argonautes, Agos 1-4, bind miRNAs in vivo (Meister et al., 
2004) and appear to be capable of mediating translational repression (to be discussed in 
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more detail in later sections of this Chapter).  This is based on the observation that 
miRNA-independent tethering of Ago2, 3 and 4 to a mRNA reporter can result in 
translational repression (Pillai et al., 2004). 
Mammalian miRNA binding sites are usually found within the 3' UTR of genes.  
miRNAs can bind and regulate a multitude of targets, while a single target can be 
regulated by a combination of miRNAs (reviewed in Kim, 2005).  Unlike endonucleolytic 
cleavage, translational repression is a cooperative mechanism, which suggests that 
target expression can be fine-tuned by altering the number of miRNA binding sites 
(Doench et al., 2003; Grimson et al., 2007; Nielsen et al., 2007). 
miRNA pairing follows a set of rules, which have been elucidated experimentally 
and by bioinformatics analyses.  Based on sequence conservation and functional 
studies, the mature miRNA can be broadly divided into two regions: a 5' and a 3' region 
(Figure 1.2).  Nucleotide positions within the 5' region, in particular positions 2-7, are 
essential for target site recognition and miRNA binding (Brennecke et al., 2005; Doench 
and Sharp, 2004; Grimson et al., 2007; Haley and Zamore, 2004; Kloosterman et al., 
2004; Lewis et al., 2005; Nielsen et al., 2007; Stark et al., 2005).  These positions have 
been termed the “seed” region and form the basis for all putative target prediction 
algorithms (Figure 1.2).  Based on conservation of 3' UTR segments containing exact 
complementarity to the seed regions of conserved miRNAs, targets for this class of 
miRNAs have been predicted (Lewis et al., 2005).  These predictions indicate that at 
least 30% of mammalian mRNAs contain one or more binding sites for conserved 
miRNAs (Lewis et al., 2005).  Based on identical nucleotide sequence within the seed 
region, miRNAs can be clustered into families.  Members of the same miRNA family are 
thought to regulate overlapping set of genes.  The 3' region of the miRNA is not 
necessary for miRNA binding, but it can compensate for weak 5' regions and can 
contribute to silencing (Brennecke et al., 2005; Doench and Sharp, 2004; Grimson et al., 
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2007; Haley and Zamore, 2004).  Although examples of miRNA:target interactions with 
some degree of complementarity to both the 5' and 3' region of the miRNA exist, 
bioinformatics analyses indicate that the majority of conserved animal miRNA target 
interactions only involve the miRNA seed (Brennecke et al., 2005; Lewis et al., 2005). 
 In addition to the miRNA seed (positions 2-7), two recent studies have also 
identified other determinants that confer greater miRNA-mediated silencing and can be 
incorporated into miRNA target predictions for better accuracy of miRNA binding and 
specificity (Grimson et al., 2007; Nielsen et al., 2007).  Base pairing at position 8 and an 
A at position 1 on the target transcript correlated with stronger miRNA repression than 
seed matches alone.  Based on the degree of silencing conferred by each of these 
determinants, a hierarchy for seed matches has been proposed: at one end of the 
spectrum is the seed match alone (referred to as a “6 mer” seed match type) which is 
associated with the lowest level of miRNA-mediated silencing among the different seed 
match types in the hierarchy.  At the other end of the spectrum is the seed match plus 
the combinations of these newly discovered determinants: pairing at positions 1 (the 
nucleotide in the target is an A) and 8 (referred to as an “8 mer” seed match type), which 
is associated with the highest degree of miRNA-mediated silencing among seed match 
types (Grimson et al., 2007; Nielsen et al., 2007).  In addition to the determinants 
uncovered at positions 1 and 8, an A or a U at position 9 in the target, irrespective of 
complementarity to the miRNA, also correlates with stronger miRNA-mediated silencing 
(Nielsen et al., 2007).  Furthermore, these two studies also reported that binding site 
context can play a significant role in miRNA-silencing.  For example, increased miRNA-
mediated silencing correlated with the following: 1) proximity of binding sites to the stop 
codon or the end of the 3' UTR; 2) increased conservation and A/U-rich content of 
sequences surrounding binding sites; and 3) close proximity of binding sites (Grimson et 
al., 2007; Nielsen et al., 2007).  Target site accessibility and mRNA secondary structure 
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have also been previously reported as important indicators of robust siRNA-mediated 
and miRNA-mediated silencing (Ameres et al., 2007; Cullen, 2006; Gregory et al., 2004; 
Heale et al., 2005; Long et al., 2007; Luo and Chang, 2004; Overhoff et al., 2005; 
Schubert et al., 2005) underscoring the importance of binding site context for both 
miRNA and siRNA-mediated silencing. 
miRNA-mediated regulation: translational repression 
The mechanistic details of how miRNAs inhibit protein expression remain highly 
controversial.  Several studies using different systems have revealed contradictory 
results.  Early miRNA experiments in C. elegans indicated that miRNAs repress protein 
synthesis at a step after translation initiation (Olsen and Ambros, 1999; Seggerson et al., 
2002).  More recent studies have both supported and challenged this view.  Studies that 
agree with the early observations in worms, showed that miRNAs and their targets 
associate with actively translating polysomes, as demonstrated by their sensitivity to 
drugs that inhibit translation such as hippuristanol, puromycin, and pactamycin (Maroney 
et al., 2006; Nottrott et al., 2006; Petersen et al., 2006).  Additional evidence that 
miRNAs repress translation at a step after initiation comes from the observation that 
silencing still occurs for a reporter with a virus internal ribosome entry site (IRES) 
(Petersen et al., 2006).  IRESs can initiate translation independently of the cap structure.  
Therefore, these experiments indicate that miRNA inhibition takes place at a step after 
cap recognition (Petersen et al., 2006).  Exactly how miRNAs affect inhibition of 
translation at a step after initiation is not known.  Based on the observation that 
ribosomes associated with repressed messages dissociate more rapidly after inhibition 
of translation than those associated with nonrepressed messages, it has been proposed 
that miRNAs cause premature ribosome dissociation or ribosome “drop-off” (Petersen et 
al., 2006).   
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In contrast with these studies, other in vivo and in vitro studies have concluded 
that miRNA inhibition occurs during initiation of translation (Chendrimada et al., 2007; 
Humphreys et al., 2005; Kiriakidou et al., 2007; Mathonnet et al., 2007; Pillai et al., 2005; 
Thermann and Hentze, 2007; Wakiyama et al., 2006; Wang et al., 2006).  In this group 
of studies, miRNA and their targets are not associated with polyribosomes but instead 
with the free ribosome pool.  In addition, when the cap was substituted for an IRESs or a 
nonfunctional cap, reporter constructs containing miRNA binding sites could not be 
repressed, indicating that miRNAs mediate translational repression by inhibiting cap 
recognition (Humphreys et al., 2005; Mathonnet et al., 2007; Pillai et al., 2005; 
Wakiyama et al., 2007).  
Two recent reports have illustrated two different pathways by which miRNAs 
might inhibit initiation of translation.  In one report, the Mid domain of mammalian Ago2 
was found to contain a region with sequence similarity to the cap-binding domain found 
in the translation initiation factor subunit eIF4E (Kiriakidou et al., 2007).  In eIF4E, this 
domain contains two conserved tryptophans which serve to anchor the cap’s methylated 
guanosine.  Initiation of translation begins with the recognition of the cap structure, 
m7GppN, by the eIF4E subunit of the translation initiation factor eIF4F.  These two 
tryptophan residues in eIF4E are essential for cap recognition.  In Argonaute proteins 
that are able to induce translational repression, the tryptophans have been replaced by 
two phenylalanines.  Human Ago2 binds to m7GTP and substitution of one or two of the 
conserved phenylalanines leads to inhibition of protein silencing (Kiriakidou et al., 2007).  
These results indicate that miRNA silencing inhibits translation initiation by preventing 
eIF4E from binding to the cap structure (Kiriakidou et al., 2007). 
An alternative mechanism has been proposed by Chendrimada and colleagues 
to account for miRNA repression of translation initiation.  In their report, Ago2, TRBP and 
Dicer associate with the large ribosomal subunit, 60S, and with the translation initiation 
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factor eIF6 (Chendrimada et al., 2007).  It has been recently reported that eIF6 prevents 
premature recruitment of the 40S subunit (Russell and Spremulli, 1978).  Depletion of 
eIF6 in human cells and C. elegans relieves miRNA repression, indicating that miRNAs 
might repress their targets by preventing binding of the 40S subunit to the 60S ribosomal 
subunit (Chendrimada et al., 2007).  Complicating these observations is the fact that 
eIF6 has been shown to participate in the maturation of the 60S subunit in yeast and 
humans (Basu et al., 2001; Sanvito et al., 1999; Si and Maitra, 1999).  Therefore, 
depletion of eIF6 could have secondary effects that may have affected the outcome of 
these experiments.  
Given that both miRNAs have been reported by several groups to inhibit protein 
synthesis at initiation or post initiation steps, it is hard to reconcile the different modes of 
translational repression.  It is possible that the different conclusions obtained from both 
in vitro and in vivo miRNA repression experiments are a reflection of experimental 
biases.  On the other hand, it is also possible that miRNAs repress protein expression 
through a multitude of mechanisms which vary based on cell type and context.  Based 
on tethering studies, it has been proposed that all human Argonautes are capable of 
inducing translational repression (Pillai et al., 2004).  None of the in vivo and in vitro 
miRNA repression studies have addressed which Argonautes are responsible for 
mediating translational repression in their experimental systems.  It is possible that 
different Argonautes regulate targets through different mechanisms.  It is also possible 
that the interaction of various protein components with miRNPs determines which 
mechanism predominates.  
miRNA-mediated regulation: RNA decay 
In recent years, multiple studies in C. elegans, Drosophila and mammalian cells 
have reported that miRNAs not only affect protein synthesis but also mRNA stability 
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through cleavage independent pathways (Bagga et al., 2005; Behm-Ansmant et al., 
2006; Giraldez et al., 2006; Jing et al., 2005; Lim et al., 2005; Rehwinkel et al., 2006; 
Schmitter et al., 2006; Wu et al., 2006).  miRNA-mediated transcript instability involves 
the mRNA degradation machinery used for bulk mRNA degradation. 
Bulk mRNA degradation can take place through the action of two different 
pathways.  Poly A tails are removed from transcripts targeted for destruction.  Poly A 
removal is generally followed by either progressive 3' → 5' decay catalyzed by the 
exosome, or by removal of the cap with subsequent 5' → 3' degradation catalyzed by the 
exonuclease Xrn1 (reviewed in Parker and Sheth, 2007).  The exosome is localized to 
the cytoplasm while Xrn1 localizes to small dense structures within the cytoplasm called 
processing bodies (P-bodies) that house translationally inactive mRNAs and 
components of the mRNA degradation machinery such as decapping, deadenylase 
enzymes, and accessory proteins. 
Evidence that miRNAs might regulate transcript levels first came from 
overexpression studies of two tissue specific miRNAs in HeLa cells: miR-1 (muscle) and 
miR-124 (brain) (Lim et al., 2005).  The majority of the downregulated mRNAs contained 
seed matches in their 3' UTR to either miR-1 and miR-124.  Subsequently, experiments 
with C. elegans’ let-7 target, lin-41, confirmed that miRNA-induced mRNA 
downregulation is not due to endonucleolytic cleavage between positions 10 and 11 
(Bagga et al., 2005).  Studies of several miRNAs in Drosophila, miR-430 in zebrafish, 
and mammalian miR-125 and let-7, have indicated that miRNAs mediate mRNA decay 
by involving components of the mRNA degradation machinery and inducing rapid 
deadenylation (Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu and Belasco, 
2005).  Rapid target transcript deadenylation is mediated through the recruitment of the 
CCR4-NOT deadenylase complex (Figure 1.1).  Depletion of the decapping enzymes 
Dcp1 and Dcp2, and depletion of decapping activators both prevent miRNA-induced 
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mRNA decay (Behm-Ansmant et al., 2006; Eulalio et al., 2007b).  Therefore, miRNA-
mediated mRNA decay requires both rapid deadenylation and decapping (Eulalio et al., 
2008).  In addition to decapping and deadenylation enzymes, another P-body 
component, GW182, has been implicated in rapid deadenylation of target transcripts.  
Studies in Drosophila S2 cells, mammalian cells and C. elegans have shown that 
GW182 binds Argonaute proteins and is necessary for both mRNA decay and 
translational repression (Behm-Ansmant et al., 2006; Ding et al., 2005; Liu et al., 2005a; 
Meister et al., 2005; Rehwinkel et al., 2006).  GW182 tethering to the 3' UTR of a 
reporter construct in the absence of reporter miRNA binding sites can result in both 
mRNA and translational repression of the reporter even in the absence of Ago1 
expression, Drosophila’s Argonaute protein dedicated to the miRNA pathway (Behm-
Ansmant et al., 2006).  It is currently thought that GW182 is recruited to miRNA targets 
through its interaction with Argonaute proteins, and that its recruitment marks the 
transcript for both mRNA decay and translational repression. 
The extent of a target’s overall protein knockdown due to mRNA decay through 
rapid deadenylation or translational repression likely depends on the target sequence 
and the structure of the mRNA:miRNA duplex since the same miRNA can cause mostly 
translational repression or mostly mRNA decay through deadenylation, depending on 
the target sequence (Eulalio et al., 2007b).  In addition, questions have arisen as to 
whether deadenylation is a by-product of translational repression.  Several lines of 
evidence have shown that miRNA-mediated decay can occur independently of 
translational repression.  For example, inhibition of translational repression by either the 
insertion of a stem loop structure in the 5' UTR (Wu et al., 2006), by the insertion of a 
translation incompetent cap (Mishima et al., 2006; Wakiyama et al., 2007), or by the 
addition of  translation inhibitors (Eulalio et al., 2007b; Wakiyama et al., 2007), does not 
affect miRNA-induced deadenylation or mRNA decay.  Just as deadenylation can occur 
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independently of translational repression, translational repression can also occur 
independently of deadenylation.  For example, numerous examples of miRNA targets 
that do not experience mRNA decay have been reported (reviewed in Filipowicz et al., 
2008). In addition, deletion of one of the subunits of the deadenylase complex in 
Drosophila S2 cells, NOT1, results in a dramatic reduction of miRNA-mediated mRNA 
decay, but does not fully restore protein levels, especially for targets for which the overall 
protein knockdown is due mostly to translational repression (Behm-Ansmant et al., 
2006).  Furthermore, substitution of the poly A tail of a reporter construct (with binding 
sites for mammalian miR-125b) for a 3' terminal loop affects the overall protein 
knockdown, due to a decrease in miRNA-mediated mRNA decay, but does not affect the 
extent of protein knockdown due to translational repression (Wu et al., 2006).  These 
results indicate that other pathways, which are independent of deadenylation, contribute 
to translational repression.  
Localization of miRNA-mediated repression 
Animal Argonaute proteins localize to the cytoplasm and to P-bodies (Behm-
Ansmant et al., 2006; Ding et al., 2005; Liu et al., 2005a; Sen and Blau, 2005).  This 
observation, and the fact that other P-body components have been involved in miRNA 
silencing (mainly GW182, the CCR4-NOT deadenylase complex, decapping enzymes 
and activators, and the RNA helicase RCK/p54) has led to the belief that repressed 
messages are sequestered in P-bodies, away from the translation machinery, and that 
P-bodies are important for miRNA-mediated silencing (reviewed in Filipowicz et al., 
2008).  Evidence that supported this hypothesis came from the observation that miRNAs 
and repressed messages also localize to P-bodies (Bhattacharyya et al., 2006; Jakymiw 
et al., 2005; Liu et al., 2005a; Liu et al., 2005b; Pillai et al., 2005).  Localization of 
transcripts to P-bodies is associated with mRNA degradation, although there are 
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examples in S. cerevisiae and human cells where messages can be targeted to P-
bodies in a reversible manner (Bhattacharyya et al., 2006; Brengues et al., 2005).  One 
example involves the cationic amino acid transporter (CAT-1) mRNA, which is repressed 
by the liver specific miRNA miR-122.  Repression leads to CAT-1’s accumulation in P-
bodies (Bhattacharyya et al., 2006).  Following cellular stress, such as amino acid 
starvation, CAT-1 is released from P-bodies into the cytoplasm.  This is due to binding of 
the HuR protein (an AU rich element binding protein also known as ELAV1) to the 3' 
UTR of CAT-1 (Bhattacharyya et al., 2006).   
Recently, several studies have argued against a central role for P-bodies in 
miRNA silencing (Chu and Rana, 2006; Eulalio et al., 2007a; Leung et al., 2006).  
Knockdown of P-body components not involved in miRNA-mediated silencing results in 
their dispersal, yet miRNA repression (both translational repression and mRNA decay) is 
not affected (Chu and Rana, 2006; Eulalio et al., 2007a).  Another line of evidence that 
argues against P-bodies having an important role in miRNA-mediated silencing comes 
from quantitation of Ago2 localization.  Approximately 2% of an enhanced GFP (EGFP) 
Ago2 construct localizes to P-bodies in HeLa cells and, unlike other P-body components 
such as the decapping enzymes Dcp1 and Dcp2, Ago2 localized to P-bodies exchanges 
at a much slower rate (Leung et al., 2006).  Furthermore, when components of the 
miRNA or siRNA silencing pathways are depleted, P-body formation is affected, 
indicating that macroscopic P-bodies are a consequence of miRNA silencing, rather than 
a cause (Eulalio et al., 2007a).  It is possible that miRNA repression is initiated within the 
cytoplasm and that formation of P-bodies is caused by the conglomeration of complex 
protein structures associated with mRNA decay or translationally repressed messages.  
It is important to note that P-bodies lack ribosomes and all of the translation initiation 
factors, except for eIF4E (Filipowicz et al., 2008).  Therefore, accumulation of 
translationally repressed mRNAs in P-bodies could only occur after ribosome 
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dissociation.  
In addition to their localization to P-bodies, Argonautes also localize to stress 
granules (Leung et al., 2006).  These cytoplasmic structures typically form in the setting 
of cellular stress or as the result of general inhibition of translation initiation.  Unlike P-
bodies, stress granules do contain ribosomal components, in particular the 40S subunit. 
Stress granules also contain components present in P-bodies such as eIF4E and the 
RNA helicase RCK/p54.  However, most P-body components are not present in stress 
granules and vice versa.  Argonaute proteins found in stress granules exchange rapidly 
with Argonaute cytoplasmic pools and more importantly, their localization to stress 
granules is dependent on miRNAs (Leung et al., 2006).  It is possible that these 
structures may have a role in miRNP-mediated repression.  Leung and colleagues have 
proposed that translational repression most likely occurs within the cytoplasm and that 
localization to P-bodies and stress granules probably correspond to different functional 
states of miRNP (Leung et al., 2006).  
Biological implications of miRNA function  
Individual miRNA functional studies have revealed that miRNAs influence cellular 
processes to different degrees.  One set of miRNAs regulates gene expression by acting 
as binary switches.  Deletion of these miRNAs causes strong phenotypes.  Two 
examples are the miRNA lsy-6 and miR-273 in C. elegans.  Lsy-6 and miR-273 specify 
left to right asymmetry of distinct gustatory neurons in nematode brains.  Lsy-6 is only 
expressed in the left gustatory neurons (ASEL neurons) and miR-273 is only expressed 
in the right gustatory neurons (ASER neurons) (Chang et al., 2003; Johnston and 
Hobert, 2003; Johnston et al., 2005).  Neuronal asymmetry is established by a double 
negative feedback loop in which two transcription factors mediate repression of each 
other by inducing the expression of lsy-6 in ASEL neurons and miR-273 in ASER 
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neurons (Johnston et al., 2005).  Misexpression or knockout of lsy-6 and misexpression 
of miR-273 results in failure to establish neuronal ASE asymmetry (Chang et al., 2003; 
Johnston and Hobert, 2003; Johnston et al., 2005) indicating that these miRNAs play a 
critical role in gustatory neuronal specification.   
Other miRNAs do not behave like biological switches.  Instead transcription 
seems to be the primary mode of regulation and miRNA expression acts as a secondary 
level of regulation to reinforce the first.  Deletion of these miRNAs may result in subtle 
phenotypes that can be difficult to quantify or characterize.  An example of this mode of 
regulation is miR-7 in Drosophila.  During photoreceptor differentiation, EGF activation 
leads to the degradation of the protein Yan, a repressor of miR-7 transcription (Li and 
Carthew, 2005).  The increase in miR-7 expression leads to further repression of Yan 
and maintenance of the differentiation program.  However, miR-7 mutant flies have 
normal eye development.  To observe inhibition of photoreceptor differentiation, the miR-
7 mutation was combined with an EGF signal insensitive Yan mutation, indicating that 
miR-7 reinforces the inhibition of Yan expression (Li and Carthew, 2005).  However, 
miR-7 expression is not necessary under normal developmental conditions.  
piRNAs 
Introduction to piRNAs 
piRNAs are 24-33 nucleotide RNAs that associate with Piwi proteins in the 
germline, where they are believed to repress the expression of transposons and 
repetitive elements.  Piwi proteins are a subclass of the larger Argonuate family of 
proteins (the Argonaute family will be discussed in greater detail in later sections).  
piRNAs contain a 5' monophosphate and are 3' methylated  (Horwich et al., 2007; Kirino 
and Mourelatos, 2007a; Kirino and Mourelatos, 2007b; Ohara et al., 2007; Saito et al., 
2007).   
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piRNA biogenesis 
Unlike siRNAs and miRNAs, piRNA biogenesis is independent of Drosha and 
Dicer (reviewed by O'Donnell and Boeke, 2007) and is believed to involve Piwi proteins.  
In Drosophila, where piRNA biogenesis has been studied in detail, three Piwi family 
members are associated with piRNA biogenesis:  Piwi, Aubergine and Drosophila Ago3.  
Piwi and Aubergine bind to piRNAs that preferentially begin with a U and match the 
antisense strand of transposons.  In contrast, Ago3 lacks a preference for a U at the 5' 
end.  Instead, it preferentially binds piRNAs that match sense transposon strands and 
have an A at position 10.  In addition, the distance between the 5' end of complementary 
piRNAs is 10 nucleotides.  A model has been proposed to explain these observations 
(Brennecke et al., 2007).  In this model, piRNAs are generated through an amplification 
loop.  Primary processing of long antisense RNA, corresponding to transposon 
sequences, generates small antisense piRNAs with a 5' U bias.  These primary piRNAs 
bind to Piwi or Aubergine, which in turn catalyze the cleavage of a complementary 
transposon transcript at a site that is 10 nucleotides downstream from the 5' end of the 
primary piRNA.  An unknown endonuclease degrades the 3' end of the cleaved 
transposon transcript to generate a secondary piRNA which corresponds to the sense 
sequence of the transposon and has an A at position 10.  This secondary piRNA binds 
to Ago3 and mediates the catalysis of a complementary transposon transcript.  The 
product of this Ago3 cleavage event is a transcript that is antisense to the transposon 
sequence and has a U at its 5' end.  Trimming of the cleaved transposon transcript’s 3' 
end by an unknown endonuclease generates a piRNA that can then bind to Piwi or 
Aubergine, starting the amplification loop once again. 
piRNA function 
In flies, piRNAs are thought to arise from master loci with transposon sequences 
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and to act in “trans” to silence copies of these transposons within the genome 
(Brennecke et al., 2007).  In mammals, however, piRNAs sequences are highly complex 
and many piRNAs map to loci that do not contain repetitive sequences.  Although 
mammalian piRNA’s function is largely unknown, knockout studies of three mouse Piwi 
proteins, Mili, Miwi and Miwi2, result in arrested spermatogenesis (review in O'Donnell 
and Boeke, 2007).  Knockout mice for Miwi2 and Mili genes also show some degree of 
transposon derepression, suggesting that in mammals, one of the functions of the piRNA 
pathway is to repress transposon activity within the germline (Aravin et al., 2007; 
Carmell et al., 2007). 
Argonaute protein family 
Introduction to the Argonaute family 
The family of Argonautes is subdivided mainly into two subfamilies:  Argonaute-
like proteins and Piwi-like proteins.  These subdivisions have been made based on the 
sequence similarities between members of this family and the two founding proteins for 
these two subgroups:  Ago1 in Arabidopsis thaliana (Bohmert et al., 1998) and Piwi (P-
element induced wimpy testis) in Drosophila (Lin and Spradling, 1997).  There is a third 
class of Argonaute proteins which have only been found in C. elegans and are 
phylogenetically different from Argonaute-like and Piwi-like proteins.  
Each organism in which RNAi has been studied possesses differences in the 
number and type of Argonautes.  The most simple example is S. pombe which has only 
one Argonaute protein.  On the other end of the spectrum is C. elegans, which 
possesses 27 Argonautes: 5 Argonaute-like proteins, 3 Piwi-like proteins and 19 C. 
elegans specific Argonautes corresponding to the third class of Argonaute proteins.  
Humans have a total of 8 Argonautes: 4 Argonaute-like proteins (Ago1, 2, 3 and 4) and 4 
Piwi-like proteins (Hili, Hiwi1, 2 and Piwi3) (reviewed in Hutvagner and Simard, 2008).  
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In mammals, Ago1, 2, 3 and 4 are associated with siRNAs and miRNA function while 
Piwi proteins has been implicated in germ cell development and piRNA biology, a 
distinct class of small silencing RNAs found in animals.   
Argonaute structure 
Argonaute proteins contain three different domains: PAZ, Mid and PIWI domains. 
X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy of individual 
domains and full length archaeal Argonaute proteins have identified structural features 
important for Argonaute function (Lingel et al., 2003; Lingel et al., 2004; Ma et al., 2004; 
Parker et al., 2004; Parker et al., 2005; Rashid et al., 2007; Rivas et al., 2005; Song et 
al., 2003; Song et al., 2004; Yan et al., 2003; Yuan et al., 2005).  The PAZ domain is 
found in both Argonaute-like and Piwi-like proteins (Cerutti et al., 2000).  The PAZ 
domain has a binding pocket that is able to recognize 2 nucleotide 3' overhangs, which 
are characteristic of small RNA processing by RNAse III enzymes (Lingel et al., 2003; 
Lingel et al., 2004; Ma et al., 2004; Song et al., 2003; Yan et al., 2003).   
The PIWI domain of Argonautes has a RNAse H-like fold.  RNAse H enzymes 
cleave RNA-DNA duplexes by a mechanism that involves the conserved catalytic triad 
Asp-Asp-Glu/Asp and two divalent metal ions (reviewed in Hutvagner and Simard, 
2008).  Argonaute proteins, on the other hand, cleave RNA-RNA duplexes using a more 
degenerate catalytic triad, Asp-Asp-Asp/Glu/His/Lys and one divalent metal ion 
(Hutvagner and Simard, 2008).  Argonaute products also contain features that are 
characteristic of RNAse H cleavage events: a 3' hydroxyl and a 5' phosphate.  Human 
Ago2 has a catalytic triad that consists of Asp/Asp/His.  As previously mentioned, human 
Ago2 is the only one of the four human Argonaute proteins that has been shown to have 
catalytic activity in vitro (Liu et al., 2004) despite the fact that the catalytic residues are 
also conserved in Ago3 (Liu et al., 2004).  It is not known what specifications might be 
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associated with endonucleolytically inactive Argonautes.  Of all the Argonautes and Piwi 
proteins identified so far, only 7 have been shown directly to contain catalytic activity:  S. 
pombe’s only Ago protein, Arabidopsis Ago1 and 4, Drosophila Ago1 and 2, Drosophila 
Piwi and human Ago2 (Hock and Meister, 2008).   
The Mid domain lies between the PAZ and the PIWI domains.  The interface 
between the PIWI and Mid domain binds the 5' phosphate of small RNAs via its 
interaction with a divalent cation (Ma et al., 2004; Song et al., 2004).  In addition, 
metazoan Argonautes contain a conserved motif within the Mid domain, called MC, with 
homology to the cap-binding motif found in eIF4E (Kiriakidou et al., 2007).  It has been 
suggested that one way in which Argonaute proteins inhibit protein synthesis is by 
competing with eIF4E binding for the cap structure and thereby preventing translation 
initiation (Kiriakidou et al., 2007).  Structural studies performed with a bound ssRNA 
have also revealed why Argonaute-mediated cleavage always occurs at a fixed position.  
Anchoring of the 5' phosphate between the Mid and the PIWI domain positions the 
scissile phosphate on the target RNA between positions 10 and 11 in front of the 
catalytic triad.  Pairing between the guide strand of a siRNA and the transcript target 
leads to the formation of an A-form helix (a structure formed by dsRNA), which is 
essential for endonucleolytic cleavage (Chiu and Rana, 2003). 
Small silencing RNA loading and sorting into Argonaute containing complexes 
How do small RNAs distinguish among different Argonaute containing miRNPs?  
The answer to this question is complex and depends on the organism that is examined 
and whether or not specialized pathways exist for either siRNA or miRNA silencing. The 
best studied example is in Drosophila which has two different Argonautes and Dicer 
proteins.  In flies, Dicer-1 and Ago1 are mainly associated with the miRNA pathway.  
siRNAs are processed by Dicer-2 and its partner R2D2, whereas miRNAs are processed 
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by Dicer-1 and its partner Loquacious (Okamura et al., 2004, reviewed in Tomari and 
Zamore, 2005).  However, whether a siRNA or a miRNA gets shuttled into Ago1 or Ago2 
containing miRNPs does not depend on which of the two Dicer enzymes it binds, but 
rather on the structure of the small silencing RNA duplex.  Perfectly matched duplexes, 
such as siRNA precursors, bind to Ago2 while mismatched duplexes, such as most 
animal miRNAs, are shuttled to the Ago1 pathway (Forstemann et al., 2007; Tomari et 
al., 2007).  In Drosophila, Ago1 cannot mediate RNAi effectively because it is a poor 
endonuclease.  Conversely, Drosophila Ago2 cannot effectively translationally repress 
miRNA targets with central bulges (Forstemann et al., 2007).  Similar studies in C. 
elegans, which also has specialized Argonuate proteins for the siRNA and miRNA 
pathways, correlate with the finding in Drosophila that duplex structure determines to 
which Argonuate containing complex the small RNA will bind (Steiner et al., 2007).   
Deep sequencing of small RNAs associated with different Argonaute proteins in 
plants has uncovered a different mechanism for small silencing RNA sorting (Mi et al., 
2008; Montgomery et al., 2008).  Plants have a diverse number of small RNAs.  In 
addition to miRNAs, plants have 3 classes of endogenous siRNAs.  Each different small 
RNA class preferentially binds to a different Argonaute protein (reviewed by Kim, 2008).  
Bioinformatic analyses of small silencing RNAs associated with different Argonautes 
have uncovered a strong 5' nucleotide bias for each Argonaute (Mi et al., 2008) 
indicating that Argonaute sorting in plants is dependent not on the structure of the small 
silencing RNA duplex but on its sequence.  However, 5' nucleotide bias cannot explain 
all small RNA binding preferences.  For example, plant miR-390, which, based on 
sequence, should bind to plant Ago1 or Ago2, actually binds to Ago7, even when the 5' 
nucleotide of miR-390 is mutated to a nucleotide that is not associated with Ago7 binding 
(Montgomery et al., 2008). 
In mammals, the distinction between the siRNA and miRNA pathways is less 
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clear.  Both miRNAs and siRNAs can interchangeably enter either pathway (Doench et 
al., 2003; Hutvagner and Zamore, 2002) and mammals possess only one Dicer protein. 
Mammalian Ago1, Ago2 and Ago3 have been shown to bind siRNAs in vivo despite the 
fact that only Ago2 has catalytic activity in vitro and is therefore thought to be the only 
Argonaute that can mediate siRNA silencing in mammals (Liu et al., 2004).  As 
previously mentioned, all four human Argonautes can bind miRNAs (Meister et al., 2004) 
and induce translational repression of a reporter in vivo (Pillai et al., 2004).  Although 
most mammalian studies have focused on studying Ago2’s function because of its ability 
to induce both mRNA cleavage and translational repression, the role that the other 
human Argonautes play with respect to small RNA silencing is not clear.  This makes 
deciphering how siRNAs and miRNAs partition within mammalian Argonautes a 
challenging problem. 
RNAi-based applications 
Introduction to RNAi-based experimental applications 
The discovery that chemically synthesized siRNAs can trigger RNAi in vivo 
(Elbashir et al., 2001b) has heralded a revolution in research, making it possible to 
knockdown genes of interest and to perform large scale screens using RNAi based 
libraries in mammalian cells and other nongenetically tractable systems.  Up to this 
point, the use of RNAi in mammalian systems had not been successful because long 
dsRNAs are potent triggers of the nonspecific interferon response.  In addition, RNAi 
technology has the potential to be used as a medical therapy.   
RNAi’s growing importance as an experimental and therapeutic tool, has 
necessitated the study of the specificity of siRNA-mediated silencing.   
siRNA specificity  
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Early RNAi studies concerned with siRNA design and specificity, investigated the 
effect of mismatches in the mRNA and siRNA duplex on overall protein silencing 
(Elbashir et al., 2001c).  Single nucleotide perturbations within the mRNA:siRNA duplex 
eliminated almost completely protein silencing of a target reporter in vitro, suggesting 
that siRNA mediated silencing was highly specific (Elbashir et al., 2001c).  Other early 
reports supported these conclusions (Chi et al., 2003; Ding et al., 2003; Semizarov et al., 
2003).  For example, a siRNA that is complementary to a mutant allele transcript of the 
superoxide dismutase 1 (SOD1) gene was successful at distinguishing between wildtype 
and SOD1 mutant transcripts in vivo and in vitro.  Wildtype and mutant SOD1 transcripts 
varied by only one nucleotide at position 10 (Ding et al., 2003).   
More recently, however, microarray data obtained after transfection of 
complementary siRNAs against the mitogen-activated protein kinase 14 (MAPK14), 
revealed unintended mRNA downregulation of transcripts with partial complementarity to 
the MAPK14 siRNAs (Jackson et al., 2003).  Prior studies had indicated that unintended 
siRNA-mediated regulation could be a consequence of high siRNA concentration 
(Semizarov et al., 2003).  However, Jackson and colleagues showed that unintended 
transcript downregulation, known as “off-target” effects, occurs even when low levels of 
siRNAs are transfected (Jackson et al., 2003).  Different siRNA sequences targeting the 
MAPK14 transcript, produced unique expression signatures.  Furthermore, off-target 
effects were observed even at early time points after transfection when target protein 
expression, MAPK14, had not yet changed, indicating that off-target effects are not a 
secondary effect caused by downregulation of the intended target’s protein level 
(Jackson et al., 2003).   
Clues that off-target effects could be related to miRNA-mediate mechanisms 
came from comparison of off-target transcripts and the transfected siRNAs that result in 
their downregulation.  The 3' UTR of off-target transcripts contained partially 
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complementarity sequences to the 5' region of the MAPK14 siRNAs (Jackson et al., 
2003).  This type of interaction is reminiscent of miRNA interactions with target 
transcripts.  Although complementarity to the 3' region of the miRNA strand can increase 
miRNA-mediated silencing, complementarity to the 5' region or seed is sufficient to 
confer repression (Brennecke et al., 2005; Doench and Sharp, 2004; Grimson et al., 
2007).  In addition, transfection of tissue specific miRNAs in HeLa cells revealed that 
miRNAs can also induce mRNA downregulation of target transcripts.  Similar to the RNA 
changes reported after ectopic introduction of miRNAs into HeLa cells (Lim et al., 2005), 
off-target effects are associated with modest 1.5 to 2-fold RNA changes (Jackson et al., 
2003; Jackson et al., 2006a; Jackson et al., 2006b).  In addition, off-target transcript 
microarray data has been used to uncover determinants besides the seed region, that 
correlate with increased off-target mRNA downregulation.  The off-target determinants 
uncovered were the same as the miRNA determinants associated with increased target 
silencing (see “miRNA function and target recognition” section for further information) 
(Nielsen et al., 2007). 
Even though off-target effects are typically associated with modest amounts of 
RNA downregulation, off-target effects can still have phenotypic consequences (Fedorov 
et al., 2006; Kleinman et al., 2008; Lin et al., 2005).  For example, reduction in cell 
viability has been observed as a consequence of off-target effects.  These phenotypic 
effects are dependent on Ago2 function, indicating that they are not the result of 
interferon-like responses (Fedorov et al., 2006).  The standard recommendation for 
designing and performing RNAi based gene knockdown experiments has been to utilize 
several different siRNAs for the same target.  If the same phenotype is observed with 
several siRNAs, then it is unlikely that the phenotype is due to off-target gene silencing 
(Jackson and Linsley, 2004).  More recently, it has been shown that a 2' -O-methyl 
ribosyl substitution at position 2 of the guide strand can decrease off-target effects by up 
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to 80% without affecting on-target silencing (Jackson et al., 2006a).  
Although off-target effects have been associated with phenotypic consequences, 
the full extent of off-target effects is not fully understood.  One major limitation of off-
target studies is their use of transcript levels as a surrogate for protein expression.  In 
Chapter 2, I will describe the effects on both mRNA and protein levels for a panel of 
mismatched mRNA:siRNA combinations.  In addition, I will describe mechanistic 
experiments aimed at elucidating the role of Ago2 in off-target RNA and protein effects.  
In Chapter 3, I will discuss the characterization of a set of mismatched and 
complementary mRNA:siRNA combinations that resulted in high protein/RNA 
knockdown ratios.  Finally, in Chapter 4 I will discuss the implications of the findings in 
Chapter 2 and 3 for both off-target effects and miRNA function and explore future 
experiments. 
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Figures 
 
 
Figure 1.1 - siRNA and miRNA pathways in mammalian cells. 
On the left: the miRNA pathway. miRNAs originate from hairpin precursors called pri-miRNAs.  
miRNAs are transcribed by Pol II and contain a cap and a polyA tail.  They are first processed by 
Drosha/DGCR8 in the nucleus to yield the ~ 70 nucleotide pre-miRNA precursor.  pre-miRNAs 
are further processed in the cytoplasm by Dicer/TRBP to yield a 20-23 nucleotide long duplex 
(miRNA/miRNA*).  miRNA strand selection occurs in a cleavage independent manner.  The 
strand with the less thermodynamically stable 5' end is incorporated into the miRNP (miRNA 
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strand).  Most mammalian miRNAs targets contain partially complementary sequences to 
miRNAs within their 3' UTR.  miRNAs mediate translational repression and/or mRNA decay 
through rapid deadenylation.  On the right: the siRNA pathway.  Long dsRNA precursors are 
processed by Dicer/TRBP into 21 nucleotide long duplexes.  Similarly to miRNA strand 
selection, the strand with the less thermodynamically stable 5' end, the guide strand, is 
incorporated into RISC.  The other strand, the passenger strand, is cleaved by Ago2 and is 
subsequently degraded.  siRNAs bind to transcripts with perfect complementarity and mediate 
endonucleolytic cleavage of the target mRNA between positions 10 and 11 of the mRNA:siRNA 
duplex.  miRNAs can perform target cleavage and siRNAs can mediate translational repression. 
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Figure 1.2 - Schematic representation of animal miRNA target interactions. 
Most animal miRNAs are only partially complementary to target sequences.  The seed 
(nucleotides 2-7) within the 5' region of the miRNA strand is essential for miRNA binding and 
function.  Binding to the 3' region is not necessary for miRNA function, but it can enhance 
silencing and compensate for weak 5' binding sites.  Some animal miRNA target sites have 
complementarity in both the 5' and 3' regions and often, these miRNA:target interactions contain 
central bulges, which prevent endonucleolytic cleavage by Ago2.  However, the majority of 
animal miRNA targets are complementarity to only the 5' region.
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Introduction 
Short interfering RNAs (siRNAs) have emerged as a powerful experimental tool 
to study gene function given their ability to cause downregulation of target messages in 
a sequence-specific manner.  Complementary siRNAs mediate sequence-specific 
silencing by inducing mRNA cleavage and subsequent mRNA degradation of target 
transcripts.  siRNAs guide the RNA-induced silencing complex (RISC) to mediate 
endonucleolytic cleavage of the target mRNA at the site opposite the 10th and 11th 
position of the guide siRNA strand (Martinez et al., 2002).  Within the RISC complex, 
cleavage is catalyzed by a specific member of the Argonaute protein family (Liu et al., 
2004; Song et al., 2004).  Although all four mammalian Argonaute proteins are capable 
of binding both siRNAs and microRNAs (miRNAs), only Argonaute 2 (Ago2) is able to 
perform RNA cleavage in mammals (Liu et al., 2004).  
siRNA-mediated mRNA downregulation was initially reported to be highly specific 
(Chi et al., 2003; Semizarov et al., 2003).  Additionally, several reports demonstrated 
that even single nucleotide mismatches between the siRNA strand and the target mRNA 
greatly decreased the rate of target mRNA cleavage (Ding et al., 2003; Haley and 
Zamore, 2004; Martinez, 2004).  However, microarray analyses have shown that siRNAs 
with only partial complementarity to mRNAs can also cause a reduction in the RNA 
levels of a large number of transcripts (Jackson et al., 2003; Jackson et al., 2006b).  This 
type of mRNA regulation has been termed an “off-target” effect and is typically 
associated with less than two-fold mRNA downregulation (Birmingham et al., 2006; 
Holen et al., 2005; Jackson et al., 2003; Jackson et al., 2006b; Lin et al., 2005; 
Persengiev et al., 2004; Saxena et al., 2003; Scacheri et al., 2004; Schwarz et al., 
2006).  Further analysis of the off-target mRNAs revealed that this mRNA effect is 
determined by complementarity of the mRNA to the 5' region of the guide siRNA strand.  
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This type of complementarity is reminiscent of canonical miRNA regulation, in which the 
same 5' region plays a central role in mRNA:miRNA interactions (Brennecke et al., 2003; 
Brennecke et al., 2005; Doench and Sharp, 2004; Kloosterman et al., 2004).  This 
region, specifically nucleotides 2-7 at the 5' end of the miRNA strand, is considered the 
“seed region” (Lewis et al., 2005).   mRNA complementarity to the 3' region of a miRNA 
is not generally required for miRNA function, but it is likely that additional 
complementarity to this region results in enhanced miRNA-mediated downregulation 
(Brennecke et al., 2005; Doench et al., 2003). 
More recently, microarray experiments identified changes in the mRNA levels of 
a large number of transcripts in HeLa cells after transfection of siRNAs corresponding to 
two tissue-specific miRNAs, miR-1 in muscle cells and miR-124 in neuronal cells (Lim et 
al., 2005).  A high percentage of the downregulated transcripts (88% for miR-1 and 76% 
for miR-124) had complementarity to the seed region of the corresponding miRNA.  
These results indicate that the interaction between the seed region of a partially 
complementary siRNA guide strand and a particular mRNA could be similar to the 
interaction observed between a miRNA and its target.  Further analysis revealed that 
compared to all other cell types, the specific tissue in which the miRNA was exclusively 
expressed also exhibited the lowest expression of the downregulated transcripts.  This 
biological correlation indicates that the downregulated transcripts identified by this 
microarray study are most likely endogenous targets of miR-1 and miR-124.  Thus, in 
this case the “off-target” interactions between the miR-1 and miR-124 siRNAs and their 
corresponding downregulated mRNAs probably reflect the physiological interaction 
between a miRNA and its target mRNA population.   
The finding that partially complementary siRNAs can cause reductions in mRNA 
levels suggests that mammalian miRNAs could regulate their targets by decreasing 
mRNA levels, in addition to attenuating translation.  Support for this hypothesis has been 
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provided by several studies, which independently reported that miRNAs can reduce the 
mRNA levels of partially complementary target genes (Bagga et al., 2005; Behm-
Ansmant et al., 2006; Giraldez et al., 2006; Jing et al., 2005; Lim et al., 2005; Rehwinkel 
et al., 2006; Schmitter et al., 2006; Wu and Belasco, 2005; Wu et al., 2006).  Zebrafish 
miR-430, for example, has been shown to downregulate hundreds of maternal mRNAs 
during early embryonic development (Giraldez et al., 2006).  Furthermore, two miRNAs 
that had been reported previously to act primarily by translational repression, 
Caenorhabditis elegans lin-4 and let-7, also reduce the levels of their target transcripts, 
lin-14 and lin-28 (Bagga et al., 2005).  It is not well understood how miRNAs mediate the 
downregulation of mRNA targets.  It is known that at least some miRNAs direct mRNA 
degradation through deadenylation and subsequent degradation of target transcripts 
(Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu et al., 2006).  This process 
probably involves processing bodies (P-bodies), which are cytoplasmic sites of mRNA 
degradation (Jakymiw et al., 2005; Liu et al., 2005a; Sen and Blau, 2005).  In addition, 
there is evidence that at least one miRNA, miR-16, mediates the rapid destruction of 
certain AU-rich element (ARE) containing mRNAs by targeting these transcripts for ARE-
mediated mRNA degradation (Jing et al., 2005).  Given the similarities between off-
target mRNA downregulation and miRNA-mediated RNA degradation, it is likely that 
both of these effects share common mechanisms. 
Previous experiments in our lab suggested that siRNAs designed to function like 
miRNAs induced strong protein reduction with little change in mRNA levels (Doench et 
al., 2003).  In these experiments, HeLa cells were transiently transfected with a siRNA 
that bound to four or six partially complementary binding sites in the 3' UTR of a 
luciferase reporter construct.  Using the same siRNAs and targets, we subsequently 
observed a two-fold decrease in mRNA levels when the mRNAs were expressed from 
an integrated gene (data not shown).  Under these conditions, the silencing at the 
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protein level was 30-fold.  In this chapter, we address the question of whether 
interactions between partially complementary siRNA guide strands and mRNAs produce 
tightly correlated changes in mRNA degradation and translational efficacy.  We have 
concentrated on dissecting the biological significance of positions 9-11 in off-target gene 
regulation given the importance of the siRNA central region in mRNA cleavage (Haley 
and Zamore, 2004).  To this end, single base substitutions at positions 9-11 were 
introduced in stably expressed reporters containing two identical siRNA binding sites 
and used different siRNAs to create various mRNA:siRNA combinations.  Quantitative 
RNA and protein analysis was performed in parallel for each combination to measure the 
degree of silencing at the RNA and protein levels.  To probe the potential mechanisms 
involved in off-target mRNA downregulation, degradation products (corresponding to the 
3' UTR of an endogenous gene) generated by partially complementary siRNAs have 
been mapped and the importance of Ago2 in this process has been assessed.   
In this chapter various mRNA: siRNAs combinations that result in different levels 
of mRNA reduction are described.  Instances in which the extent of mRNA and protein 
knockdown do not correlate were observed, underscoring the importance of assessing 
siRNA-mediated effects by measuring both mRNA and protein levels.  Furthermore, 
isolation and sequencing of degradation products identified a variety of products; some 
are likely the result of a canonical siRNA cleavage event while others are probably 
generated by Ago2-independent degradation processes.  
Results 
Importance of complementarity within positions 9-11 for off-target effects 
 Off-target mRNA downregulation could be due to endonucleolytic cleavage 
reminiscent of canonical siRNA cleavage.  When a siRNA is perfectly complementary to 
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its target site, canonical siRNA cleavage occurs between the 10th and 11th nucleotides 
opposite the siRNA guide strand.  Therefore, we decided to test whether 
complementarity within this region is important for off-target mRNA downregulation.  
Single mismatches in this region of complementarity are known to reduce dramatically 
mRNA cleavage in vitro (Haley and Zamore, 2004; Martinez, 2004; Schwarz et al., 
2006).  We designed six 3' UTR constructs containing two binding sites for a siRNA 
against the chemokine C-X-C motif receptor 4 (CXCR4) with single base substitutions in 
either the 9th, 10th or 11th positions.  Each CXCR4 binding site is base paired at position 
8 and contains an adenosine in position 1, opposite the siRNA guide strand.  Both of 
these features were associated with the strongest degree of mRNA downregulation for 
miR-1 and miR-124 targets and for a large set of off-target interactions (Grimson et al., 
2007; Nielsen et al., 2007).  Thus, this sequence configuration allows for maximal mRNA 
knockdown in our studies.  Two binding sites were used instead of one to increase the 
strength of potential siRNA-mediated effects.  For each construct, the two identical 
binding sites were cloned into the 3' UTR of the reporter Renilla reniformis luciferase 
gene (Renilla luciferase).  Five different siRNAs were used to generate a total of 30 
mRNA:siRNA combinations: 28 mRNA:siRNA combinations containing single and 
double mismatches at the 9th, 10th, and/or 11th positions, and 2 perfectly complementary 
mRNA:siRNA combinations (Table 1).   
The Renilla luciferase constructs containing variations of the CXCR4 binding site 
in their 3' UTRs were transfected into HeLa cells and stable cell lines were established.  
These cell lines were transfected with 5 nM of siRNA.  This concentration was chosen 
after titration experiments with a stably expressed Photinus pyralis luciferase reporter 
construct (firefly luciferase) containing six binding sites, showed that the resulting two-
fold decrease in mRNA levels did not vary significantly with increasing siRNA 
concentrations (data not shown).  RNA and protein levels were measured at 48 hours 
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post-transfection.  This duration was selected because both maximal RNA and protein 
knockdown are observed at 48 hours.  Time course experiments performed with two of 
the five siRNAs utilized in this study, CXCR4 and CXCR4-B (Figure 2.1, Table 1), 
indicated that mRNA downregulation peaks 24 hours after siRNA transfection and 
remains relatively the same 48 hours post-transfection, whereas protein knockdown 
peaked 48 hours after siRNA treatment (Figure 2.1 A, B).  A 48 hour time point after 
siRNA transfection is typically necessary to observe both maximum RNA and protein 
knockdown for most genes.  RNA and protein analyses were performed by quantitative 
real-time PCR and luciferase assays, respectively.  Both of these assays have the 
advantage of being highly quantitative, allowing the detection of even small changes in 
both RNA and protein.  For each mRNA:siRNA combination, RNA and protein 
measurements were made from three to five independent experiments and the average 
results are reported.  
Changes in the 9th, 10th, and 11th positions had varied effects on both mRNA and 
protein levels (Figure 2.2 and Table 1).  In all cases, the decrease in luciferase activity 
was greater than the decrease in mRNA levels.  This suggested that the reduction in 
protein was the result of a combination of mRNA downregulation and translational 
repression (Figure 2.2 A).  Perfectly complementary combinations 13 and 27 resulted in 
an average 4.9 + 1.2-fold mRNA decrease and an average 7.5 + 1.6-fold protein 
knockdown (Figure 2.2 A and Table 1).  Transient transfections of combinations 13 and 
27 resulted in higher degree of RNA and protein knockdown (data not shown).  
Therefore, reductions in mRNA and protein levels greater than the ones reported here 
for stable transfections are probably limited by the fraction of cells successfully 
transfected. 
The average RNA and protein decrease for all the mRNA:siRNA combinations 
was 2.1 + 0.1-fold and 4.0 + 0.2-fold, respectively.  Notably, 43% of the combinations 
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containing mismatches between the 9th and the 11th position resulted in at least a two-
fold mRNA decrease (Figure 2.2 A).  Many of these downregulated mRNA:siRNA 
combinations contained both single and double mismatches in the 9-11 region.  This 
degree of mRNA knockdown paralleled the two-fold mRNA reduction that we have 
previously observed between the imperfectly complementary CXCR4 siRNA and the 
firefly reporter construct containing six CXCR4 binding sites (Petersen et al., 2006).  
Several important observations emerged from RNA and protein analysis of the 
30 different mRNA:siRNA combinations.  First, changes at the protein level do not 
always correlate with changes at the RNA level.  In some cases, there were large 
changes in protein levels with only small changes in mRNA levels (Figure 2.2 A, Table 1 
and Table 2).  Subgroups of responses resulting from different combinations are 
apparent when the results are plotted as the normalized average mRNA knockdown 
versus the ratio of normalized protein knockdown to normalized mRNA knockdown (with 
all values expressed as fold change) (Figure 2.2 B, Table 2).  One subgroup contains 
mRNA:siRNA combinations that are significantly regulated at the mRNA level with 
similar changes at the protein level (Figure 2.2 B, subgroup I - combinations 9, 13, and 
27).  As expected, this subgroup largely consists of perfect combinations (13 and 27, 
Table 1).  A second subgroup of mRNA:siRNA combinations caused intermediate, 2-3 
fold changes at both mRNA and protein levels (Figure 2.2 B, subgroup II - combinations  
1, 3, 5, 7, 8, 11, 12, 15, 17-21, 23-26, 29, and 30).  These first two subgroups 
demonstrate protein changes that closely parallel changes at the mRNA level (Table 2).  
A third subgroup is composed of a series of combinations which produced moderate 
protein downregulation despite very little mRNA knockdown (Figure 2.2 B, subgroup III - 
combinations 2, 10, 16, 22, and 28).  Finally, the last subgroup includes only two 
combinations (4 and 6), both of which caused a large degree of protein knockdown and 
exhibited little to no change in mRNA levels.  One possible explanation for the small 
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change in RNA observed for these combinations at the 48 hour time point is that the 
mRNA might then be recovering from repression while the protein levels still reflect the 
repressed state.  In other words, it is possible that G:U wobbles at positions 9 or 10 are 
downregulated with different kinetics than perfect and mismatched combinations.  
However, this alternative explanation is unlikely because the siRNA that gave rise to 
combinations 4 and 6, CXCR4 siRNA, (G:U wobbles at position 10 and 9, respectively) 
was also utilized for the time point experiments previously described.  These 
experiments established that Renilla luciferase mRNA repression begins to recover after 
the 48 hour time point (Figure 2.1 A, B).  In addition, the Renilla luciferase reporter used 
in these experiments has a protein half-life of approximately 5 hours (Bronstein et al., 
1994).  It is unlikely that the mRNA recovered substantially from siRNA repression with 
no detectable recovery at the protein level.  Therefore, the third and fourth subgroups 
likely reflect combinations for which protein knockdown is largely due to translational 
repression.   
RNA and protein analysis showed that different types of mismatches resulted in 
different degrees of protein knockdown.  Among all nucleotide changes, single G:U 
mismatches at position 9 or 10 correlated with the highest levels of translational 
repression (combinations 4 and 6, Table 1, and Table 2).  For example, a single G:U 
mismatch at the 10th position (combination 4) resulted in protein knockdown (5.13 + 1.1-
fold) comparable to that of perfectly complementary mRNA:siRNA combinations (13 and 
27, Table 1).  This particular G:U mismatch, however, failed to cause mRNA 
degradation.  The G:U mismatch in the 9th position, combination 6, showed higher 
protein knockdown (10.7 + 3.7-fold) in comparison to perfect complementary 
mRNA:siRNA combinations 13 and 27 (Figure 2.2 A, Table 1, and Table 2 ).  The mRNA 
levels for this combination decreased only two-fold.  Unlike single G:U mismatches, 
double nucleotide changes containing both a G:U mismatch and a second mismatch 
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resulted in protein knockdown equivalent to that observed for double nucleotide changes 
that do not have G:U mismatch (Figure 2.3).  The average protein knockdown for these 
mRNA:siRNA combinations was 2.9 + 0.3-fold.  For combinations containing two 
mismatches other than a G:U, the average protein knockdown was 3.0 + 0.2-fold (Figure 
2.3).  
We also considered whether the type of nucleotide at positions 9-11 in the mRNA 
affected the degree of mRNA knockdown.  We observed an average mRNA knockdown 
of 2.6 + 0.1-fold for mRNA reporter constructs containing a combination of purine and 
pyrimidine nucleotides at positions 9-11 (all combinations contained in the 1st, 3rd and 5th 
columns of Table 1).  In contrast, mRNA reporter constructs containing all pyrimidine 
nucleotides in positions 9-11 caused a smaller, 1.3 + 0.1-fold mRNA decrease (all 
combinations contained in the 2nd, 4th and 6th columns of Table 1).  This analysis 
excluded complementary mRNA:siRNA combinations 13 and 27.  However, the average 
protein knockdown for reporter mRNAs containing either purines and pyrimidines at 
positions 9-11, or pyrimidines only, was 3.7 + 0.2-fold and 3.7 + 0.3-fold, respectively.  
Therefore, for these combinations, the nucleotide composition of positions 9-11 affected 
the degree of mRNA knockdown, but not the degree of protein knockdown.  These 
results suggest that mRNA suppression may be greater if a purine base is present in the 
9-11 region in mismatched mRNA:siRNA interactions, while translational repression 
might not be affected in these circumstances.  
Imperfectly complementary siRNA binding yields canonical cleavage 
products  
We observed mRNA decreases even when mismatches were created at 
positions 10 and 11, the same positions that are engaged by canonical siRNA-mediated 
cleavage and that are important for the efficiency of this process (Haley and Zamore, 
Chapter 2: Comparison of siRNA-induced off-target RNA and protein effects 
 54 
2004).  To determine if decreases in mRNA caused by imperfectly complementary 
siRNAs could result from endonucleolytic cleavage within the siRNA binding site, we 
mapped 3' terminal degradation intermediates after transfection with two siRNAs that 
bound with imperfect complementarity to the endogenous Cxcr4 gene.  These 
experiments focused on an endogenous gene to permit mapping of degradation 
products relative to a single siRNA binding site on a mRNA.  One siRNA, CXCR4-A, 
resulted in a mismatch at position 10.  The other siRNA, CXCR4-B, resulted in a 
mismatch at position 11 (Figure 2.4 A).  In addition, three control siRNAs were used: one 
with perfect complementarity to the endogenous Cxcr4 gene, and two unrelated siRNAs 
against green fluorescent protein (GFP) and firefly luciferase respectively.  Mapping of 
degradation products was performed using rapid amplification of cDNA ends (5' RACE) 
on mRNA from HeLa cells 48 hours after siRNA transfection.  Canonical siRNA-
mediated cleavage at position 10 results in a 3' cleavage product that contains a 5' 
phosphate and can therefore act as a substrate for 5' RACE (Kasschau et al., 2003).  
Various reports have shown that the 3' cleavage product is degraded by the 5' → 3' 
exonuclease Xrn1 and that 3' fragments accumulate when Xrn1 is suppressed (Gazzani 
et al., 2004; Orban and Izaurralde, 2005; Souret et al., 2004).  To stabilize the 3' 
cleavage products resulting from direct siRNA targeting in our experiments, Xrn1 was 
concomitantly knocked down by RNAi.  
5' RACE analysis of RNA from cells transfected with the previously mentioned 
siRNAs revealed bands of approximately 250 base pairs, which is consistent with the 
size of the expected amplified cleavage product and the location of the primers used 
during nested PCR (data not shown).  In total, 171 amplified products were sequenced 
and analyzed.  43% (73/171) of the degradation products mapped to the siRNA binding 
site, while 57% (98/171) of the degradation products mapped to regions upstream and 
downstream of the siRNA binding site (Figure 2.4 B, C).  Notably, 93% (68/73) of the 
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products that mapped to sequences spanning the siRNA target site were recovered from 
cells transfected with either perfectly or imperfectly complementary CXCR4 siRNAs.  In 
contrast, only 7% (5/73) of the products that mapped to sequences spanning the siRNA 
target site were recovered from cells transfected with control siRNAs.  These results 
indicate that the cleavage products corresponding to the siRNA-targeted region were 
likely generated by the specific binding of perfectly and imperfectly complementary 
CXCR4 siRNAs.  Significantly, 47% (34/73) of the products that mapped to the 
sequence spanning the siRNA target site corresponded to the canonical cleavage site 
(10th position).  These sequences were only recovered from cells transfected with 
CXCR4 siRNAs.  As expected, the perfectly complementary CXCR4 siRNA yielded 
degradation products that corresponded to the canonical cleavage site.  45% (20/44) of 
the degradation products recovered from cells transfected with the perfectly 
complementary CXCR4 siRNA mapped to the canonical cleavage site.  This percentage 
is similar to prior results reported for analysis of siRNA-directed cleavage (Schmitter et 
al., 2006).  In addition, 48% (21/44) of the degradation products recovered from cells 
transfected with the perfectly complementary CXCR4 siRNA mapped to sites that were 
1-3 nucleotides downstream of the canonical cleavage site.  No degradation products 
were recovered that mapped upstream of the canonical cleavage site for the CXCR4 
siRNA.  These results suggest that the degradation products that mapped closely 
downstream of the canonical cleavage site for the perfectly complementary CXCR4 
siRNA might represent canonical cleavage products that are in the process of being 
degraded. 
As previously noted, sequence analysis of amplified products resulting from 
treatment with the imperfectly complementary siRNAs CXCR4-A and CXCR4-B, 
revealed a low percentage of cleavage products that corresponded to the canonical 
siRNA cleavage site (Figure 2.4 C).  26% (10/39) of the products recovered from cells 
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transfected with the CXCR4-A siRNA mapped to the canonical cleavage site, whereas 
14% (4/28) of the products recovered from cells transfected with the CXCR4-B siRNA 
mapped to the canonical cleavage site.  None of the degradation products recovered 
from cells transfected with the control siRNAs mapped to the canonical siRNA cleavage 
site.  This observation suggests that the degradation products that were cloned from 
cells transfected with imperfectly complementary siRNAs and whose sequences mapped 
to the 10th position are likely the result of canonical siRNA-directed cleavage events.  
Some off-target mRNA changes probably occur via Ago2-independent 
degradation pathways  
As previously mentioned, perfectly complementary siRNA-mediated cleavage at 
position 10 is probably the result of endonucleolytic cleavage by Ago2, the only 
Argonaute family member that is cleavage-competent.  Canonical cleavage products 
were cloned when imperfectly complementary siRNAs were transfected, suggesting that 
cleavage at position 10 might be the primary mechanism for downregulating off-target 
mRNAs.  To test this hypothesis, we knocked down Ago2 in cells stably expressing one 
of the Renilla luciferase reporter constructs and measured RNA levels after transfection 
with an imperfectly complementary siRNA as described previously.  
For these experiments, the cell line that stably expresses a Renilla luciferase 
reporter construct with a UAC trinucleotide at positions 9-11 was utilized (mRNA reporter 
in column 3, Table 1).  Two CXCR4 siRNAs were used following Ago2 knockdown: one 
with perfect complementarity to the target sequence (combination 27, Table 1) and 
another with two mismatches at positions 10th and 11th (combination 15, Table 1).  Cells 
were first transfected with Ago2 siRNAs and then transfected again with a CXCR4 
siRNA 16 hours later.  The cells were collected 48 hours after the Ago2 siRNA 
transfection.  As a control, GFP siRNA was also transfected on the same day as Ago2 
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siRNAs to assess the effect of an unrelated siRNA transfection on Renilla luciferase 
mRNA levels.  
The extent of mRNA knockdown due to the perfectly and imperfectly 
complementary CXCR4 siRNAs was not significantly affected by the GFP siRNA 
transfection (Figure 2.5 A).  mRNA knockdown due to the perfectly complementary 
CXCR4 siRNA decreased two-fold when Ago2 was also knocked down.  In contrast, 
mRNA knockdown due to transfection of the imperfectly complementary siRNA changed 
less than two-fold.  Ago2 mRNA levels were reduced 12.8 + 4.8 -fold and 10.9 + 4.5 -fold 
in cells transfected with perfectly and imperfectly complementary siRNAs, respectively 
(Figure 2.5 B).  Given that the same degree of Ago2 knockdown was observed for cells 
transfected with perfectly or imperfectly complementary siRNAs, insufficient Ago2 
knockdown is not a likely explanation for why the mRNA reporter levels were not 
significantly changed for the imperfectly complementary mRNA:siRNA combination.  
These results indicate that Ago2 mediated cleavage and/or other functions performed by 
Ago2 are not solely responsible for off-target mRNA reductions and that other processes 
are probably involved in destabilizing off-target mRNAs.   
To verify that Ago2 is not required for imperfectly complementary siRNA 
mediated mRNA downregulation, imperfectly complementary combinations 25 and 15 
were transiently transfected into AGO2-/- MEFs (Liu et al., 2004) together with either a 
control plasmid or a plasmid expressing wild type human Ago2.  Their complementary 
counterpart combinations, combinations 13 and 27, were used as controls.   
In keeping with the results observed when Ago2 expression was knocked down 
by RNAi, loss of Ago2 expression produced a marked decrease in RNA and protein 
downregulation for both complementary siRNA combinations tested (Figure 2.6 A, B).  In 
contrast, loss of Ago2 expression did not significantly alter the extent of mRNA or protein 
downregulation for the two imperfectly complementary combinations tested (Figure 2.6 
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A, B).  These results confirmed that Ago2 is not required for the silencing mechanisms 
that result from imperfectly complementary duplexes.  Interestingly, both perfectly 
complementary combinations tested still experienced some degree of mRNA and protein 
downregulation in the absence of Ago2 expression.  For example, in the presence of the 
control plasmid, the complementary combination with a GCC trinucleotide sequence at 
positions 9-11 (combination 13) resulted in 2.1 + 0.0 and 2.9 + 0.2 -fold knockdown for 
mRNA and protein changes, respectively, and the complementary combination with a 
UAC trinucleotide sequence at positions 9-11 (combination 27) resulted in 3.6 + 0.8 and 
6.2 + 1.0 -fold knockdown for mRNA and protein changes, respectively.  This result 
indicates that in the absence of Ago2, complementary siRNAs can still enter other 
Argonaute containing miRNPs to induce mRNA and protein downregulation.  
Furthermore, both complementary combinations result in higher degrees of protein than 
mRNA knockdown in the absence of Ago2 expression, particularly combination 27, 
indicating that under certain circumstances, complementary combinations can mediate 
translational repression. 
Discussion 
Imperfectly complementary siRNAs frequently induce a moderate mRNA 
reduction.  When this effect is observed in the context of the targeting of a specific 
mRNA by a perfectly complementary siRNA, these mRNA reductions are considered off-
target effects.  This effect may also be typical of mRNA:miRNA interactions.   
There is an incomplete understanding of the contribution of off-target effects to 
the phenotypes that result from siRNA targeted gene knockdown experiments.  There 
are several reports of unanticipated phenotypes generated by a siRNA to a specific 
mRNA, with off-target effects implicated in some cases (Fedorov et al., 2006; Kleinman 
et al., 2008; Lin et al., 2005; Scacheri et al., 2004).  A recent study that examined the 
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effects of siRNAs on cell physiology observed that 29% (51/176) of a large siRNA 
population targeting two nonessential transcripts led to a reduction in cell viability of over 
25% (Fedorov et al., 2006).  This phenotype correlated mainly with the presence of a 
UGGC motif within the siRNA guide strand.  However, the general finding that 
expression of siRNAs from integrated short hairpin RNAs (shRNAs) can result in 
silencing of the target gene with little detectable effect on cell viability suggests that 
detrimental off-target effects are not common.  In the experiments discussed in this 
chapter, only one of the siRNAs utilized contained the UGGC motif (CXCR4 siRNA) and 
none caused a reduction in cell viability.  Therefore, the effects observed at the RNA and 
protein level in our results are likely mediated by partial complementarity to the siRNAs 
utilized, and are unrelated to cell toxicity.  
Published studies of off-target effects have focused largely on evaluating off-
target mRNA regulation (Birmingham et al., 2006; Chi et al., 2003; Jackson et al., 2003; 
Persengiev et al., 2004; Semizarov et al., 2003).  The effects of off-target regulation at 
the protein level have been characterized for only a few siRNA:mRNA combinations.  In 
one of these studies, the degree of protein knockdown correlated with the previously 
observed changes in mRNA levels (Jackson et al., 2006b).  In two other studies, off-
target gene regulation was largely associated with changes in protein levels and with 
less than two-fold changes in RNA (Saxena et al., 2003; Scacheri et al., 2004).  The 
study described in this chapter is the first in which off-target changes in both protein and 
mRNA levels are characterized systematically for a large number of mRNA:siRNA 
interactions.   
Imperfectly complementary siRNAs can cause a spectrum of actions.  At one end 
of the spectrum, we observe certain imperfectly complementary interactions that yield 
mRNA degradation with little additional translational repression.  Conversely, certain 
mismatches result in significant protein reduction with little or no change in mRNA levels.  
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Other mRNA:siRNA interactions fall in the middle of the spectrum, yielding some degree 
of mRNA degradation and translational repression.  These results indicate that off-target 
activity can include regulation at the protein level that is independent of mRNA 
downregulation.  Indeed, 7 of the 30 siRNA:miRNA combinations studied here exhibited 
robust changes in protein levels and little or no change in mRNA levels (Table 2).  Two 
combinations (4 and 6) in this group had exact complementarity except for a G:U wobble 
in either positions 9 or 10 (Table 1).  The other 5 examples (combinations 2, 10, 16, 22, 
and 28) corresponded to mRNA targets with only pyrimidines in positions 9-11 (Table 1).  
A similar spectrum of mRNA and protein effects has recently been observed 
following transfection of a siRNA corresponding to a muscle cell specific miRNA, miR-1.  
Using stable isotope labeling with amino acids in cell culture (SILAC), Vinther and 
colleagues investigated the effects of transfecting miR-1 into HeLa cells on protein 
expression and compared these changes with previously identified mRNA changes 
determined by microarray analysis.  There was a slight overlap between the genes 
repressed by miR-1 at the mRNA and protein levels.  In fact, 4 targets were identified for 
which corresponding protein and RNA repressions were observed.  This report identified 
only 12 proteins that were repressed by miR-1 transfection (Lim et al., 2005; Vinther et 
al., 2006).  
Our detailed analysis of the different mismatch types tested revealed that G:U 
wobbles in positions 9 and 10, unlike other types of mismatches, resulted in significant 
protein knockdown with only modest changes at the mRNA level.  Others have reported 
a loss in silencing at both the protein and mRNA levels with a G:U wobble at position 10 
(Holen et al., 2005; Schwarz et al., 2006).  However, in agreement with our results, 
Saxena and colleagues have observed that G:U wobbles in the central region of the 
mRNA:siRNA duplex results in protein knockdown, similar to the degree of protein 
knockdown observed for perfectly complementary siRNAs, with little change in mRNA 
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levels (Saxena et al., 2003).  This effect could potentially be explained if a G:U wobble in 
positions 9 and 10 caused a perturbation in the helix minor groove of the mRNA:siRNA 
duplex, leading to inhibition of endonucleolytic cleavage, but not binding.  Consistent 
with this hypothesis, Haley and Zamore have reported that base pairs formed by the 
central region of the siRNA guide strand contribute to formation of an A-form helix 
required for mRNA cleavage, but are not necessary for siRNA binding (Haley and 
Zamore, 2004). 
Mapping of endogenous Cxcr4 degradation products generated after treatment 
with various imperfectly complementary siRNAs suggests that a siRNA-directed Ago2 
cleavage event probably contributes to a fraction of the modest mRNA reduction we 
observed.  26% (10/39) and 14% (4/28) of the degradation products generated by the 
imperfectly complementary siRNAs CXCR-A and CXCR4-B, respectively, mapped to 
position 10.  In contrast to our results, other studies have not found that imperfectly 
complementary siRNA or miRNA binding results in the generation of canonical cleavage 
products.  Degradation products of the C. elegans let-7 mRNA target, lin-41, mapped 
outside of the two let-7 binding sites (Bagga et al., 2005).  Similarly, 5' RACE 
experiments performed on a luciferase reporter construct containing the 3' UTR of the 
mammalian miR-125b target, lin-28, did not yield degradation products that mapped 
within the miR-125b binding sites (Wu et al., 2006).  A recent study observed that most 
of the degradation products recovered from a luciferase reporter containing three let-7 
binding sites in its 3' UTR mapped within the actual binding sites.  However, none of the 
degradation products corresponded to the canonical cleavage site at position 10 
(Schmitter et al., 2006).  Compared to prior studies, it is possible that the higher degree 
of complementarity between our mRNA and siRNAs contributed to our detection of 
cleavage at the canonical position 10.  Simultaneous knockdown of Xrn1, which 
stabilizes 3' cleavage products, may also have contributed to our detection of canonical 
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cleavage.   
If reductions in mRNA levels were due primarily to canonical cleavage, then 
Ago2 inhibition should suppress the mRNA reductions observed with partially 
complementary siRNAs.  However, we observed only a minor suppression of mRNA and 
protein changes when Ago2 was knocked down or completely absent in these cases.  
Thus, we conclude that an Ago2-independent pathway is also important in mediating 
downregulation of mRNA levels.  Schmitter and colleagues have recently reported 
similar results, demonstrating that degradation of a luciferase reporter containing three 3' 
UTR let-7 binding sites in mammalian cells only partially decreases when Ago2 is 
concomitantly knocked down (Schmitter et al., 2006).  Another strong indication of an 
Ago2-independent pathway for off-target mRNA degradation in our results is the 
mapping of numerous non-canonical 5' RACE products to sequences spanning the 
siRNA binding site.  Similar products were very rare in cells transfected with control 
siRNAs.  These products are probably generated by processes that are stimulated by 
the binding of a siRNA in an Ago2-independent fashion.  Recently, various reports have 
implicated several Drosophila miRNAs, zebrafish miR-430, and mammalian let-7 and 
miR-125b in promoting deadenylation of target transcripts and subsequent mRNA decay 
(Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu et al., 2006).  It appears likely 
that this pathway or another pathway yet to be defined is the Ago2-independent pathway 
responsible for a large majority of the mRNA changes observed with off-target 
interactions.  
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Material and Methods 
DNA constructs 
EGFP control plasmid and wild type human Ago2 constructs we obtained from the 
Tuschl lab (Meister et al., 2004).  Briefly, EGFP and wild type Ago2 constructs 
containing a N-terminal FLAG/HA tag were cloned into a modified pIRESneo plasmid 
(Meister et al., 2004).  The firefly expressing reporter GL3 (Promega) was used for 
transient transfections to control for transfection efficiency. 
Construction of stable cell lines 
A modified version of the pRL-TK vector containing a multiple-cloning site downstream 
of the Renilla luciferase stop codon was generated (pRL-TK 3'MCS).  To create stable 
cell lines that expressed different Renilla luciferase reporters, a pRL-TK 3'MCS Bgl 
II/HpaI fragment containing the Renilla luciferase gene and the SV40 poly A signal was 
cloned into a pPur BamHI/SwaI fragment containing the puromycin resistance gene 
(pRL-TK 3'MCS Pur).  3' UTR binding sites were constructed by annealing two DNA 
oligonucleotides containing two identical CXCR4 binding sites separated by the 
sequence CCGG and flanked by XhoI and SpeI sites.  Annealed oligos were then 
inserted into pRL-TK 3'MCS Puro’s XhoI and SpeI sites, which are located directly 
downstream from the Renilla luciferase coding region.  HeLa cells were then transfected 
with the modified pRL-TK 3'MCS Puro constructs containing different versions of the 
CXCR4 binding sites and selected with puromycin (600 ng/mL). 
siRNAs 
siRNAs were purchased from Dharmacon and prepared according to manufacturer’s 
instructions. Sequences of siRNAs (sense strand) used in this study are as follows:  
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CXCR4: 5'- GUUUUCACUCCAGCUAACAdTdT -3';  
CXCR4-A: 5'- GUUUUCACUGCAGCUAACAdTdT -3';  
CXCR4-B: 5'- GUUUUCACGCCAGCUAACAdTdT -3';  
CXCR4-C: 5'- GUUUUCACUCGAGCUAACAdTdT -3';  
CXCR4-D: 5'- GUUUUCACUACAGCUAACAdTdT -3';  
GFP: 5'- GGCUACGUCCAGGAGCGCAdTdT -3';  
Firefly luciferase: 5'- CUUACGCUGAGUACUUCGAdTdT -3';  
Ago2-1: 5'- GCACGGAAGUCCAUCUGAAUU -3';  
Ago2-2: 5'- GCAGGACAAAGAUGUAUUAUU -3';  
Xrn1-beta: 5'- GUACCUGGAUAUACUAAGAdTdT -3';  
Xrn1-delta: 5'- CUACUCAAGUACCUACUAAdTdT -3' 
Cell culture and transfections 
Cell lines expressing Renilla reporter constructs or AGO2 -/- MEFs obtained from the 
Hannon lab (Liu et al., 2004) were grown in DMEM supplemented with 10% inactivated 
fetal bovine serum and penicillin/streptomycin.  For stable cell line transfections, the day 
before transfection, cells were seeded at 1.5X105 cells/well for 6-well plates and 3.0X104 
cells/well for 24-well plates in antibiotic-free media.  Transfections were performed using 
Oligofectamine according to the manufacturer’s instructions (Invitrogen) in a final volume 
of 1.25 mL for 6-well plates and 0.25 mL for 24-well plates.  For transient transfections, 
the day before transfection, cells were seeded at 5.5X105 cells/well for 6-well plates and 
1.0X105 cells/well for 24-well plates in antibiotic-free media.  Transfections were 
performed using Lipofectamine 2000 according to the manufacturer’s instructions 
(Invitrogen) in a final volume of 2.50 mL for 6-well plates and 0.50 mL for 24-well plates. 
For the transient AGO2 -/- MEFs’ transfections, the Renilla reporter with a GCC and a 
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UAC trinucleotide at position 9-11 were transfected at a final concentration of 1.1 ng/µl, 
the firefly reporter construct (GL3, Progema) was transfected at a final concentration of 
0.1 ng/µl, and the EFGP control vector or the wild type human Ago2 containing plasmids 
were transfected at a final concentration of 0.4 ng/µl.  For stable and transient 
transfections siRNAs were used at a final concentration of 5 nM or 10 nM, respectively, 
except when indicated otherwise. 
Real Time RT-PCR 
For detection of Renilla mRNA, total RNA was harvested 48 hrs after transfection using 
the RNAeasy kit (Qiagen) and DNAse-treated with RNA Free DNAse Set (Qiagen).  4 or 
5 µg of RNA were used for reverse transcription reactions with specific primers for 
Renilla luciferase (Rluc) and TATA binding protein (TBP), which served as an internal 
control.  The following are the reverse transcription primers for TBP and Rluc: TBP RT 
primer 5'-GTACATGAGAGCCATTACGTCGTC-3'; Rluc RT primer 5'-
GCATTCTAGTTGTGGTTTGTCC-3'.  The Rluc RT primer is located downstream of the 
3' UTR CXCR4 binding sites.  Reverse transcription was performed using EndoFree RT 
(Ambion) or Superscript III (Invitrogen) according to manufacturer’s guidelines.  For the 
stable cell line transfections, the resulting cDNA was diluted 1/5 or 1/10 and either 1 or 4 
µl of diluted cDNA were subjected to real-time PCR .  For the transient transfections 1 µl 
of the reverse transcription reaction was subjected to real-time PCR.  Each PCR 
reaction was measured in quadruplicate.  Rluc primers and probe were designed against 
the cDNA junction between pRL-TK vector sequence and the Renilla luciferase exon 
(pRL-TK contains a chimeric intron upstream of the Renilla reporter gene).  The 
following are the primers and Taqman probes used for amplification of Rluc and TBP: 
Rluc forward primer (FP) 5'-TGCAGAAGTTGGTCGTGAGGCA-3'; Rluc reverse primer 
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(RP) 5'-TCTAGCCTTAAGAGCTGTAATTGAACTGGG-3'; Rluc probe 5’-FAM-
TGGGCAGGTGTCCAC-MGB-NFQ-3' (FAM: 6-carboxy-fluorescin; MGB: minor groove 
binding; NFQ: nonfluorescent quencher; Applied Biosystems); TBP primers and probe 
were obtained from Applied Biosystems (Taqman Gene Expression Assays, # 
Hs00427620_m1).  Real-time PCR was performed in a total volume of 25 µl, using the 
Taqman Universal PCR Master Mix protocol according to manufacture’s instructions.  
Final concentrations of probes and primers used per reaction were 250 nM and 900 nM, 
respectively.  Increasing concentrations of cDNA were utilized to determine the linear 
range of real-time PCR.  Titration experiments with five increasing concentrations of 
cDNA revealed that the TBP and Rluc Taqman probes and primers resulted in Ct values 
that were in the linear range.  TBP and Rluc Taqman probe and primers both 
demonstrated a linear correlation with a R2 value of 0.995 and 0.992, respectively.  
Subsequent experiments that utilized both TBP and Rluc Taqman probe/primers were 
performed with cDNA concentrations that were within the linear range established by the 
titration experiments.  Relative mRNA levels were determined using the 2-∆∆Ct method.  
Control experiments measuring the change in ∆Ct with different template dilutions 
showed similar efficiencies of amplification for the Renilla luciferase and TBP Taqman 
probes/primers.  mRNA amounts were normalized to GFP siRNA transfections.  For 
detection of Ago2 and Xrn1 mRNA levels, total RNA was harvested 48 hours after 
transfection as previously described.  250 ng of RNA were utilized for reverse 
transcription reactions with oligo(dT).  Reverse transcription was performed as 
previously described.  1 µl of resulting cDNA was subjected to real-time PCR using 
Syber Green primers (SYBR).  Each PCR reaction was measured in quadruplicate.  The 
following are the primers used for amplification of Ago2, Xrn1 and TBP, which served as 
an internal control: Ago2 FP 5'-CGCGTCCGAAGGCTGCTCTA-3'; Ago2 RP 5'-
TGGCTGTGCCTTGTAAAACGCT-3'; Xrn1 FP 5'-AGCTTTCGACTCCCGTTTCTCCAA-
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3'; Xrn1 RP 5'-GGCCAACACATATCCTGGGTTGTA-3'; TBP FP 5'-
GGAGAGTTCTGGGATTCTAC-3'; TBP RP 5'-TTATCCTCATGATTACCGCAG-3'.  Real 
time was performed in a total volume of 20 µl, using the SYBR Universal PCR Master 
Mix protocol according to manufacturer’s instructions.  Relative mRNA levels were 
determined as previously described.  Real-time reactions were conducted in an ABI 
PRISM 7000 Sequence Detection System Thermal Cycler (Applied Biosystems).  
Luciferase Assays 
Renilla luciferase assays were performed 48 hours after transfection according to 
manufacturer’s instructions (Promega) and detected with an Optocomp I luminometer 
(MGM Instruments).  Each transfection reaction and luciferase assay was done in 
triplicate.  All of the readings obtained from luciferase assays were within the linear 
range (seven orders of magnitude) established by both the manufacturer (Promega) and 
by titration experiments previously performed in our lab.  For Renilla luciferase assays, 
Renilla luciferase activity was assayed and normalized to a GFP siRNA or a siControl 
siRNA (Dharmacon) transfection.  For dual luciferase assays, Renilla and firefly 
luciferase activities were consecutively assayed.  Renilla luciferase readings were first 
normalized to firefly luciferase readings.  Relative Renilla luciferase counts were then 
normalized against a GFP or a siControl siRNA (Dharmacon) transfection.  
5' RACE  
HeLa cells were transfected with 100 nM of Xrn1 siRNAs (Xrn1-beta and Xrn1-delta) and 
5 nM of unrelated siRNAs (targeting GFP or Firefly luciferase) or 5 nM of perfectly and 
imperfectly complementary CXCR4 siRNAs.  Total RNA was harvested 48 hrs after 
transfection using the RNAeasy kit (Qiagen) and DNAse-treated with RNA Free DNAse 
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Set (Qiagen).  4 µg of RNA were ligated to a synthetic RNA oligonucleotide adaptor 
(GCUGAUGGCGAUGAAUGAACACUGCGUUUGCUGGCUUUGAUGAAA) by treatment 
with T4 RNA ligase (2 units, New England Biolabs) for 1 hour at 37 ˚C.  After the ligation 
reaction, RNA was phenol/chloroform-extracted and precipitated with ethanol.  Ligation 
products were reverse-transcribed using oligo (dT) primer and EndoFree RT (Ambion) 
according to manufacturer’s guidelines.  The resulting cDNAs were amplified by 
successive rounds of PCR with nested pair of primers.  The first round of PCR was 
performed for 20 cycles using the following primers: RNA adaptor outer FP 5'-
GCTGATGGCGATGAATGAACA-3' and CXCR4 outer RP 5'-
CCTGCCTAGACACACATCA-3'.  The second round of PCR was performed for 35 
cycles using the following primers: RNA adaptor inner FP 5'- 
ACACTGCGTTTGCTGGCTTTGATG-3' and CXCR4 inner RP 5'-
GAGACATACAGCAACTAAGAACT-3'.  RT-PCR products were examined by 
electrophoresis, gel-purified and cloned into pCR2.1TOPO vector for sequencing 
(Invitrogen). 
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Table 1 - RNA and protein knockdown for 30 mRNA:siRNA 
combinations 
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Table 2 - Protein/RNA knockdown ratios for 30 miRNA:siRNA 
combinations 
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Figures 
 
Figure 2.1 - Time course of RNA and protein knockdown for a perfect and 
imperfectly complementary combination. 
(A) RNA and (B) protein analysis of a stably expressed Renilla luciferase reporter after 
transfection of 5 nM of a perfectly complementary siRNA, CXCR4-B siRNA (combination 27, 
Perf), or an imperfectly complementary siRNA, CXCR4 siRNA (combination 1, Impf).  Cells 
were collected for RNA and protein analysis 12, 24, 48 and 72 hours after transfection.  Samples 
were normalized to an unrelated siRNA (targeting GFP, Control).  A siRNA targeting the coding 
sequence of Renilla luciferase was used as a positive control (Renilla).  RNA and protein analysis 
for (A) and (B) was performed by quantitative real-time PCR and Renilla luciferace assays, 
respectively.  Normalized average mRNA and protein knockdown (fold change + SD) are shown.  
mRNA sequences (black) and guide siRNA sequences (red) for positions 9-11 are shown for 
relevant combinations. 
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Figure 2.2 - Effects of mismatches in positions 9-11 on mRNA and protein levels.  
(A) Average normalized RNA and protein reductions, expressed as fold change, of the 30 
mRNA:siRNA combinations (Table 1).  Five CXCR4 siRNAs (Table 1) each containing a single 
nucleotide change within positions 9-11 were transfected into 6 different stable cell lines 
expressing Renilla luciferase reporters, which also contained a single nucleotide change within 
positions 9-11 in both CXCR4 binding sites.  Cells were collected for RNA and protein analysis 
48 hours after transfection.  RNA analysis was performed by quantitative real-time PCR.  TBP 
was used as an internal control.  Protein analysis was performed by Renilla luciferase assays.  For 
both RNA and protein analysis, samples were normalized to an unrelated siRNA (targeting GFP) 
transfection.  For each mRNA:siRNA combination, the average normalized RNA and protein 
reductions (fold change) were calculated from at least three independent experiments.  Each bar 
graph represents the average normalized RNA reduction (orange) overlapped with the average 
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normalized protein reduction (green), both expressed as fold change, for a particular 
mRNA:siRNA combination.  Each combination is numbered and represented in Table 1.  (B) 
Ratio of normalized protein knockdown to normalized RNA knockdown (fold change) for each of 
the 30 mRNA:siRNA combinations.  The normalized protein reduction (expressed as fold 
change) of each mRNA:siRNA combination was divided by its corresponding normalized mRNA 
reduction (fold change) to calculate the ratio between these two measurements.  The protein to 
RNA ratio was then plotted versus normalized RNA knockdown (fold change) for each 
combination. The combinations were grouped into four distinct subgroups (labeled I-IV) 
according to their distribution in this plot. 
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Figure 2.3 - Comparison of G:U wobble effects on mRNA and protein knockdown 
with those of mismatched combinations for positions 9-11. 
Average mRNA and protein knockdown for G:U wobble combinations without other types of 
mismatches (Combinations 4 and 6, Table 1) were compared to the average mRNA and protein 
knockdown for single mismatches (Combinations 1-3, 5, 9-10, 14, 23-24, 28), for combinations 
containing G:U wobbles plus a single mismatch (Combinations 12, 16, 18, 22, and 30), and for 
combinations containing double mismatches (Combinations 7-8, 11, 15, 21, 25-26, and 29).  
Normalized average mRNA and protein knockdown (fold change + S.D.) values were obtained 
from Table 1. 
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Figure 2.4 - Imperfectly complementary siRNAs result in degradation products 
that correspond to canonical siRNA-mediated cleavage events.   
(A) Schematic of the interaction between two CXCR4 siRNAs that contain nucleotide changes in 
position 10 (CXCR4-A, Impf-10th) and position 11 (CXCR4-B, Impf-11th) and the endogenous 
Cxcr4 transcript.  The perfectly complementary CXCR4 siRNA (guide strand, red) is also shown 
binding to the endogenous Cxcr4 mRNA for reference.  (B) 5' RACE analysis performed on the 
endogenous Cxcr4 mRNA after transfection with imperfectly complementary siRNAs.  HeLa 
cells were transfected with 100 nM of Xrn1 siRNAs and 10 nM of either control siRNA (GFP or 
firefly), perfectly complementary (CXCR4) or imperfectly complementary siRNA (CXCR4-A or 
CXCR4-B).  Cells were collected 48 hours after siRNA transfection and subjected to RNA 
ligation followed by reverse transcription, nested PCR and TOPO cloning.  Each number 
corresponds to a distinct degradation product.  The canonical siRNA cleavage product is 
highlighted with an asterisk.  The CXCR4 siRNAs target sequence is indicated.  (C) Summary of 
the 5' RACE analysis performed on the endogenous Cxcr4 mRNA after transfection with 
perfectly and imperfectly complementary siRNAs.  The total number of clones sequenced and the 
number of clones that mapped to each degradation site are indicated for all the transfected 
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siRNAs.  Degradation products that mapped to the siRNA binding site have been highlighted 
(yellow) and the canonical siRNA cleavage product is highlighted with an asterisk.  
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Figure 2.5 - Ago2 is not required for off-target mRNA downregulation.  
(A) RNA analysis of a stably expressed Renilla luciferase reporter after transfection of 10 nM of 
a perfectly complementary siRNA, CXCR4-D siRNA (combination 27, Perf), or 10 nM of an 
imperfectly complementary siRNA, CXCR4-B (combination 15, mismatches at position 10 and 
11, Imperf).  These cells were transfected with either 100 nM of an unrelated siRNA (targeting 
GFP, Control) or 100 nM of Ago2 siRNAs (Ago2-1 and Ago2-2) 16 hours prior to the CXCR4 
siRNAs transfections.  (B) RNA analysis of Ago2 levels for experiment in (A).  RNA analysis for 
(A) and protein analysis for (B) was performed by quantitative real-time PCR.  TBP was used as 
an internal control.  Samples were normalized to an unrelated siRNA (targeting GFP) 
transfection.  Normalized average mRNA knockdown (fold change + S.D.) was calculated from 
two independent experiments.  mRNA sequences (black) and guide siRNA sequences (red) for 
positions 9-11 are shown for relevant combinations. 
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Figure 2.6 - Ago2 is not required for off-target mRNA and protein downregulation. 
 (A) RNA and protein analysis of a Renilla luciferase reporter 48 hours after transfection of 10 
nM of a perfectly complementary siRNA, CXCR4-D siRNA (combination 27, Perf), or an 
imperfectly complementary siRNA, CXCR4-B siRNA (combination 15, Impf) into AGO2 -/- 
MEFs in the presence of a control or an Ago2 expressing plasmid.  Samples were normalized to 
an unrelated siRNA transfection (Control).  Normalized average mRNA and protein knockdown 
(fold change + S.D.) was calculated from three independent experiments.  (B) RNA and protein 
analysis of a Renilla luciferase reporter 48 hours after transfection of 10 nM of a perfectly 
complementary siRNA, CXCR4-B siRNA (combination 13, Perf), or an imperfectly 
complementary siRNA, CXCR4-D siRNA (combination 25, Impf) into AGO2 -/- MEFs in the 
presence of a control or an Ago2 expressing plasmid.  Samples were normalized to an unrelated 
siRNA transfection (Control).  Normalized average mRNA and protein knockdown (fold change 
+ S.D.) were calculated from two independent experiments.  RNA and protein analysis for (A) 
and (B) was performed by quantitative real-time PCR and Renilla luciferace assays, respectively.  
mRNA sequences (black) and guide siRNA sequences (red) for positions 9-11 are shown for 
relevant combinations.
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Introduction  
Conservation and bioinformatics analysis of miRNA seeds and the 3' UTRs of 
their putative targets have uncovered additional determinants outside of the seed that 
are important for miRNA silencing and that could be used to predict more accurately 
miRNA targets (Grimson et al., 2007; Nielsen et al., 2007).  These determinants were 
identified by comparing target sequences with degrees of target mRNA downregulation.  
Characteristics that distinguished the most downregulated RNAs from the rest of the 
RNA pool with seed matches were noted (Grimson et al., 2007; Nielsen et al., 2007).  
These characteristics include 1) having a matching nucleotide pair at position 8 together 
with the presence of A at position 1 in the target; 2) the presence of U or A at position 9 
in the target sequence; 3) proximity to other miRNA binding sites; 4) AU-rich nucleotide 
sequences near the target site; and 5) proximity of the target site with respect to the stop 
codon or the end of the 3' UTR.  However, these analyses have considered only 
changes in target transcript levels.  Comparison of quantitative changes in protein levels 
for targets that contain these determinants versus those that do not has been performed 
only for one miRNA, miR-25 (Grimson et al., 2007).  miR-25 targets containing these 
determinants experienced increased protein downregulation in comparison to those that 
do not contain these determinants.  However, it is not known whether these 
determinants can be applied generally to those miRNAs which induce silencing primarily 
through translational expression with little to no change in target transcript levels.  
In Chapter 2, we reported examples of mRNA:siRNA combinations from a large 
panel of mismatched mRNA:siRNA pairs that resulted in different levels of RNA and 
protein knockdown.  The two most striking examples of differences between RNA and 
protein knockdown were combinations that resulted in G:U wobbles at position 9 or 10 
(combinations 4 and 6, Chapter 2).  We decided to investigate these two combinations to 
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uncover determinants that contribute to large protein/RNA knockdown ratios in siRNA-
mediated silencing. 
Results 
Time course experiments of G:U wobble combinations 
In the previous chapter we compared protein and mRNA changes for 30 
mRNA:siRNA combinations with various types of mismatches in positions 9-11.  
Different silencing effects were observed for the different combinations.  In particular, 
when protein/RNA knockdown ratios were plotted for each combination, a range of RNA 
and protein knockdown effects were observed.  Some combinations such as perfectly 
complementary combinations, exhibited the same degree of protein and RNA 
knockdown, whereas other combinations exhibited differences in the extent of RNA and 
protein knockdown.  Disparity between the extent of RNA and protein knockdown was 
observed for combinations with single and double mismatches within positions 9-11.  
However, the highest protein/RNA knockdown ratios resulted from combinations with 
single G:U wobbles in positions 9 or 10.  For example, a G:U wobble combination at 
position 9 or 10 yielded a protein/RNA knockdown ratio of 5.3 and 5.7, respectively (2.0 
+ 0.6 and 10.7 + 3.7-fold RNA and protein knockdown, respectively for the G:U wobble 
at position 9; and 0.9 + 0.1 and 5.13 + 1.1-fold RNA and protein knockdown, respectively 
for the G:U wobble at position 10).  Having an additional mismatch within positions 9-11 
in conjunction with a G:U wobble resulted in comparable extent of RNA and protein 
knockdown.  These results indicated that G:U wobbles within positions 9-11 were 
unusual in that they, more so than any other type of mismatch tested, resulted in the 
highest degree of translational repression.  We were intrigued by these results and 
decided to explore these observations further. 
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To investigate further the activity of G:U wobbles at position 9 and 10, we 
performed an experiment in which RNA and protein samples were collected 24 and 48 
hours after transfection.  We wanted to verify that the differences we had previously 
observed at 48 hours between RNA and protein knockdown were not due to rapid 
mRNA recovery from siRNA repression relative to the rate of protein recovery.  
Transfections of cells stably expressing the Renilla reporter with a UCU trinucleotide at 
positions 9-11 (Column 6, Table 1, Chapter 2) were compared with transient 
transfections of the same reporter in HeLa cells.  A control siRNA that results in a bulge 
within positions 9-11 for the UCU reporter but which contains the same seed and 3' 
region as the siRNA that results in the G:U wobble at position 9, was also transfected.   
Both cell line and transient transfections resulted in a very similar trend of mRNA 
and protein downregulation for both siRNAs (Figure 3.1 A, B).  A bulge within the central 
region resulted in little to no RNA downregulation and only small protein changes for 
both types of transfections (Figure 3.1 A, B).  The protein/RNA knockdown ratio for the 
bulge combination was 2.0 for both cell line and transient transfections.  In contrast, in 
either transient or stable transfections, a G:U wobble at position 9 resulted in different 
extents of RNA and protein knockdown for both 24 and 48 hour time points (Figure 3.1 
A, B).  Protein/RNA knockdown ratios resulting from stable transfections of cells 
expressing the G:U wobble reporter were 2.8 and 4.0 for the 24 and 48 hour time points, 
respectively.  Protein/RNA knockdown ratios resulting from transient transfections of the 
same G:U wobble combination were 7.5 and 6.5 for the 24 and 48 hour time points, 
respectively.  These results indicate that the disparity we previously observed between 
RNA and protein knockdown for G:U wobbles within positions 9-11 in a 48 hour time 
point are not likely due to rapid mRNA recovery. 
Both RNA and protein downregulation, and protein/RNA knockdown ratios were 
more substantial for transient transfections of the G:U wobble at position 9 than for 
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stable cell line transfections of this combination (Figure 3.1 A, B).  This is probably due 
to inherent differences between the two types of transfections.  In a transient 
transfection, there is an increased probability that the reporter containing plasmid and 
siRNA are co-transfected and thus, have overlapping activities.  In a stable cell line 
transfection, siRNAs are delivered only to a fraction of the cells that stably express the 
reporter.  Given this observation and the fact that we wished to test the effect of this type 
of pairing on mRNA and protein expression in other cell types, we decided to conduct 
most of our experiments with transient transfections.  
To verify that the enhanced silencing observed for transient transfections of the 
G:U wobble combination for the UCU reporter was not due to a specific activity 
associated with the CXCR4 siRNA or the transfection conditions used for this 
experiment, the same siRNA used for creating this G:U wobble, CXCR4, was also 
transfected with three different reporters.  These reporters contain the same target 
sequence as that of the UCU reporter, except for position 9 (Figure 3.2).  A control 
siRNA that resulted in at least two mismatches at positions 9-11 for each of the reporters 
was transfected in parallel.  Dramatic silencing and discrepancy between RNA and 
protein reduction was observed only for the G:U wobble at position 9, indicating that the 
original observation was not due to a particular siRNA, but rather to the structure of the 
mRNA:siRNA combination (Figure 3.2).  
Perfectly complementary siRNAs can result in translational repression and 
enhanced silencing 
To test whether symmetry plays a role in G:U wobble mediated protein and RNA 
knockdown, we designed a reporter construct with the trinucleotide sequence UCG in 
positions 9-11.  The activities of a perfect combination and a G:U wobble combination at 
position 9 for this sequence was compared to that of a reporter with the trinucleotide 
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UCU in positions 9-11.  These two sets of reporters and their corresponding G:U wobble 
combinations tested whether symmetry is important for the G:U wobble effect at position 
9.  As controls, we used a siRNA with no complementarity from positions 10-19, and a 
siRNA which creates a bulge within positions 9-11.  These two kinds of controls should 
result in the same degree of mRNA and protein knockdown, because as described in 
Chapter 2, a G:U wobble at position 9 with an additional mismatch did not result in a 
discrepancy between mRNA and protein knockdown.  Surprisingly, both sets of perfectly 
complementary siRNAs yielded a large disparity between the degree of protein and RNA 
knockdown (Figure 3.3).  This degree of disparity between RNA and protein knockdown 
had only been observed previously for G:U wobbles at position 9 and 10 (combination 4 
and 6, Chapter 2), but not for a perfectly complementary siRNA (see combinations 13 
and 27, Table 1, Chapter 2).  As observed with G:U wobble combinations at positions 9 
or 10, the complementary combinations of reporters with trinucleotides UCU and UCG 
resulted in both disparate levels of protein and RNA knockdowns and dramatic silencing, 
as protein knockdowns from these combinations were larger than those observed with 
other previously examined perfect and mismatched miRNA:siRNA combinations (Table 
1 and data not shown).  Protein knockdown for the perfect combinations was 31 + 8.9 
and 43.9 + 9.0-fold change for the UCU and UCG reporters, respectively (Figure 3.3).   
For the perfect combinations, changing the nucleotide identity at position 9 from 
a U:A base pair to a G:C base pair, did not alter the discrepancy between protein and 
RNA knockdown (Figure 3.3).  In contrast, changing the geometry of the G:U wobble at 
position 9 significantly reduced the extent of protein knockdown, but did not alter the 
extent of RNA downregulation (5.85 + 2.11 and 6.18 + 1.08-fold change for the UCU and 
UCG reporter, respectively), resulting in a much smaller protein/RNA knockdown ratio 
(protein/RNA knockdown ratios of 6 and 2 for the UCU and the UCG reporter, 
respectively).  This result indicates that G:U wobble symmetry within positions 9-11 can 
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affect overall silencing.   
Complementarity within the 3' region or within positions 9-11 is important for high 
protein/RNA knockdown ratios for both UCU and UCG reporters (Figure 3.3).  
mRNA:siRNA combinations with no 3' complementarity (no base pairing from positions 
10-19) or with a bulge within positions 9-11, resulted in reduced levels of RNA 
knockdown, particularly for the UCG reporter.  More importantly, protein knockdown was 
approximately 10 times less for these combinations, compared to their perfectly 
complementary counterparts, resulting in a substantial reduction of protein/RNA 
knockdown ratios (Figure 3.3).  The siRNAs that generated both types of control 
combinations for each reporter, G:U wobbles without 3 complementarity and bulges 
within positions 9-11, were different for the UCU and the UCG reporters.  Nevertheless, 
they both resulted in very similar RNA and protein knockdowns (Figure 3.3), indicating 
that the high protein/RNA knockdown ratios observed for these two perfectly 
complementary combinations are not likely to have been an experimental artifact created 
by these two reporters.  Complementarity within the miRNA’s 3' region is not essential 
for miRNA targeting and binding as reported by our lab and others (Brennecke et al., 
2005; Doench and Sharp, 2004; Grimson et al., 2007; Haley and Zamore, 2004; 
Kloosterman et al., 2004; Lewis et al., 2005; Nielsen et al., 2007; Stark et al., 2005).  
However, 5' region complementarity alone is not always sufficient to mediate effective 
miRNA silencing.  For example, mutations in C. elegans cog-1’s binding site for the 
miRNA lsy-6 that disrupt 3' pairing but maintains seed pairing, resulted in the loss of 
miRNA-mediated repression (Didiano and Hobert, 2006).  
Given the surprising protein to RNA knockdown ratios generated by the perfectly 
complementary combinations for the UCU and UCG reporters, we decided to determine 
the extent of mRNA and protein silencing for the perfect duplex corresponding to the 
UUC trinucleotide, the other trinucleotide sequence at position 9-11 that had previously 
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shown high protein/RNA knockdown ratios.  This trinucleotide RNA sequence 
corresponds to combination 4, a G:U wobble at position 10, which had previously yielded 
a protein/RNA knockdown ratio of 5.6 (Chapter 2).  For this experiment, the perfectly 
complementary combination for the UUC reporter was transiently transfected.  
Combinations resulting in a G:U wobble at position 10, with an additional mismatch at 
position 11 or a bulge within the central region of the UUC reporter were also transfected 
as controls.  In addition, the perfectly complementary combination for the UCU reporter 
and its corresponding controls were transiently transfected in parallel.  Surprisingly, both 
perfectly complementary combinations resulted in degrees of mRNA and protein 
downregulation that were similar to those observed for their respective G:U wobble 
combinations at positions 9 and 10 (Figure 3.4 A, B).  As previously noted for the UCU 
reporter, the corresponding perfectly complementary combinations also resulted in a 
much higher ratio of protein/RNA knockdown.  Specifically, protein/RNA knockdown 
ratios for the perfect combinations were 8 and 6.5 for UCU and UUC reporters, 
respectively.  As expected, an additional mismatch or a bulge within positions 9-11 
resulted in smaller protein/RNA knockdown ratios for both of these reporters (Figure 3.4 
A, B).  For the reporter with a trinucleotide UCU at positions 9-11, the protein to RNA 
knockdown ratio was 4.1 for a G:U at position 9 with a mismatch at position 11.  For the 
reporter with the trinucleotide UUC, the protein to RNA knockdown ratio was 2.2 for a 
G:U at position 10 with a mismatch at position 11. 
To verify that the disparity between RNA and protein knockdown observed with 
these complementary combinations with atypical activity was not an artifact of transient 
transfections, we performed the same experiment in cells stably expressing the UCU 
reporter.  The lack of correlation between protein and RNA knockdown observed for the 
reporter with a UCU trinucleotide sequence at positions 9-11 in transient transfections 
was also observed for transfections of cells stably expressing this same reporter (Figure 
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3.4 C).  Protein/RNA knockdown ratios for the perfect mRNA:siRNA combination and the 
G:U wobble at position 9 were 3.9 and 3.2, respectively, whereas a G:U at position 9 
with an additional mismatch at position 11 or a bulge within positions 9-11 resulted in 
protein/RNA knockdown ratios of 2.4 and 2.3, respectively.  This set of experiments 
confirmed the notion that complementary siRNAs can result in translational repression in 
certain cases.  These experiments suggest that G:U wobbles at position 9 or 10 and 
their complementary counterpart combinations generate high protein/RNA knockdown 
ratios.  Furthermore, high protein/RNA knockdown for perfect and G:U wobble 
combinations is dependent on the configuration of the G:U wobble and perhaps also on 
the presence of a U or C at positions 9 and 10.   
To confirm that the atypical protein/RNA knockdown ratios observed with 
complementary combinations were not an artifact of the siRNAs transfected, we decided 
to test different preparations (both different synthesis and siRNA preparations) of the 
same siRNAs used previously.  Perfectly complementary combinations with trinucleotide 
sequences UCU and UUC at positions 9-11 were transiently transfected in HeLa cells.  
Reassuringly, both perfectly complementary combinations resulted in protein/RNA 
knockdown ratios similar to those previously observed (Figure 3.5 A).  In addition, the 
extent of RNA and protein knockdown did not change from previous experiments, 
indicating that previous results were not due to a faulty set of siRNA aliquots.   
We also endeavored to eliminate the possibility that the observed noncorrelating 
RNA and protein knockdowns for these complementary combinations could be the result 
of siRNA degradation within the siRNA preparations used for transfection, causing them 
to bind to target sites with partial complementarity, in a manner similar to miRNA 
binding.  To test for siRNA degradation, different siRNAs sequences and different 
batches of the same siRNA were 5' labeled and resolved by gel electrophoresis.  The 
extent of degradation was quantitated and compared to the radioactive signal from intact 
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siRNA.  These siRNAs and the respective preparations analyzed in this experiment 
(Figure 3.5 B, C) have been previously transfected and their effect on RNA and protein 
knockdown has been previously analyzed (see Table 1 in Chapter 2, Figure 3.3 and 
3.4). On average, siRNA degradation constituted 20% of the total radioactive signal, 
regardless of the siRNA examined, indicating that most of the siRNAs transfected were 
intact (Figure 3.5 B, C).  Therefore, the disparity observed between protein and RNA 
knockdown for various complementary combinations cannot be attributed to effects 
mediated by degraded siRNA preparations.    
Dramatic silencing resulting from atypical complementary combinations is 
Ago2-dependent 
Given that approximately 80% of the overall protein knockdown for 
complementary combinations with atypical silencing is the result of translational 
repression, we tested whether Ago2 was necessary for this activity.  The reporter with a 
UCU trinucleotide sequence at positions 9-11 was transfected with siRNAs that resulted 
in a complementary combination, a G:U wobble at position 9 (combination 6, Table 1, 
Chapter 2) and a G:U at position 9 with a mismatch at position 11 (combination 18, 
Table 1, Chapter 2).  These combinations were transfected in AGO2 -/- MEFs (Liu et al., 
2004), together with either a control plasmid, a plasmid expressing wild type human 
Ago2, or wild type human Ago1 cDNA.  It is important to note that these cells already 
express mouse Ago1 protein (Liu et al., 2004, data not shown).   
In the presence of the Ago2 containing plasmid, the extent of RNA and protein 
knockdowns for all the combinations tested were similar to those observed for transient 
transfections in HeLa cells in which Ago2 is endogenously expressed (Figure 3.6).  
Protein knockdown for complementary combinations decreased dramatically in the 
absence of Ago2 expression (AGO2 -/- MEFs transfected with a control plasmid) in 
Chapter 3: Characterization of mRNA:siRNA combinations with high protein/RNA knockdown ratios 
 89 
comparison to cells expressing Ago2 (28.7 + 3.1 and 5.7 + 0.0 -fold knockdown for Ago2 
and control plasmid transfections, respectively).  A similar decrease in protein 
knockdown was also observed for the G:U wobble combination at position 9 when AGO2 
-/- MEFs transfected with Ago2 were compared with those transfected with control 
plasmid (29.5 + 0.0 and 4 + 0.3 -fold protein knockdown, respectively, Figure 3.6).  In 
contrast, a G:U wobble at position 9 with a mismatch at position 11 (combination 18) did 
not demonstrate a substantial decrease in protein knockdown upon loss of Ago2 
expression (Figure 3.6).  Therefore, the dramatic silencing resulting from atypical 
complementary combinations is dependent on Ago2 expression.  
Loss of Ago2 expression also correlated with a substantial decrease in RNA 
knockdown for both the perfect and the G:U wobble combinations (Figure 3.6).  In the 
absence of Ago2, RNA and protein knockdown were 2.0 + 1.1 and 5.7 + 0.7 -fold 
change, respectively for the complementary combination and 1.7 + 0.6 and 4.0 + 0.3 -
fold change, respectively for the G:U wobble combination.  Notably, RNA and protein 
knockdown are still observed in the absence of Ago2.  This observation is consistent 
with the RNA and protein knockdown effect observed for other perfectly complementary 
combinations (13 and 27) when transfected in AGO2 -/- MEFs (see Chapter 2, Figure 
2.5 and Figure 2.6).  These results indicate that in the absence of Ago2, complementary 
combinations can still silence target expression by Ago2-independent mRNA 
degradation pathways as well as by translational repression, presumably through their 
interaction with other Argonaute proteins (Ago1, 3 and 4). 
The high protein/RNA knockdown ratios observed for the atypical complementary 
combinations in the presence of Ago2 decreased in the absence of Ago2, and thus are 
Ago2-dependent (Figure 3.6).  In the presence of the Ago2 containing plasmid, 
protein/RNA knockdown ratios are 4.5, 3.9 and 2.3 for the perfect combination, the G:U 
combination and the G:U with a mismatch combination, respectively.  These ratios are 
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similar to those observed for HeLa cells (Figures 3.2 and 3.3).  However, in the presence 
of control containing plasmid, protein/RNA knockdown ratios are 2.9, 2.4 and 1.9 for the 
perfect combination, the G:U combination and the G:U with a mismatch combination, 
respectively.  Interestingly, overexpression of Ago1 in AGO2 -/- MEFs resulted in similar 
protein/RNA knockdown ratios similar to those observed for the control plasmid (Figure 
3.6).  Therefore, the disparity between protein and RNA knockdown exhibited by the 
perfect and the G:U wobble combination is an effect that is dependent on Ago2 function 
and not simply the result of overexpression of Argonaute protein.  
To assess whether the dramatic silencing observed for atypical complementary 
and G:U wobble combinations is dependent on cleavage by Ago2, we transfected a 
complementary combination with atypical activity in AGO2 -/- MEFs along with a 
catalytically dead Ago2 mutant.  This Ago2 mutant construct, Ago2 D597A, has a single 
point mutation in one of the two aspartate residues that form the catalytic triad within the 
PIWI domain of Ago2 and cannot cleave a complementary RNA substrate in vitro (Liu et 
al., 2004).  This mutant can bind to siRNAs in vivo and does not affect the expression of 
Ago2 (data not shown) or its localization to P-bodies (Liu et al., 2005b).  A control or wild 
type Ago2-containing plasmid was also transfected together with the UCU reporter and 
either, 1) a complementary siRNA, 2) a siRNA that results in a G:U wobble at position 9, 
or 3) a siRNA that results in a G:U at position 9 with a mismatch at position 11.  The 
extent of RNA and protein silencing in either the presence or absence of Ago2 
expression were very similar to those observed previously (Figure 3.6 and Figure 3.7).  
However, transfection of Ago2 D597A resulted in the loss of the dramatic silencing 
effects previously observed for the perfect and the G:U wobble combination in the 
presence of Ago2 (Figure 3.7).  Protein knockdown of the perfect and the G:U wobble 
combination decreased from a 28.4 + 16.5 -fold and a 24.5 + 4.9 -fold change, 
respectively for cells transfected with wild type Ago2 to a 2.8 + 0.3 -fold and 2.6 + 0.9 -
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fold change, respectively for cells transfected with Ago2 D597A (Figure 3.7).  This result 
implicates mRNA cleavage by Ago2 in the dramatic silencing observed for the 
complementary combinations with atypical activities.  This is puzzling because, on 
average, 80% of protein reduction observed for the perfect and the G:U wobble 
combinations is due to translational repression.  As previously mentioned, Ago2 protein 
expression was not affected by the D597A change (data not shown), indicating that the 
RNA and protein knockdowns observed with Ago2 D507A are almost certainly not due to 
differences in levels of Ago2 expression.  
Discussion 
We have previously reported mismatched mRNA:siRNA combinations that 
generated dramatic differences in the degree of protein knockdown relative to RNA 
knockdown (Chapter 2).  In particular, G:U wobble combinations at positions 9 or 10 
demonstrated strikingly enhanced protein knockdown relative to RNA knockdown.  The 
results described in this chapter indicate that this observation can also be extended to 
complementary combinations, in particular to those with trinucleotides UUC, UCU and 
UCG sequences at positions 9-11. 
It is widely accepted that complementary combinations engage Ago2-containing 
RISC complexes and mediate cleavage followed by RNA degradation.  In these cases, 
the vast majority of the protein knockdown can be attributed to mRNA degradation.  This 
type of siRNA-mediated silencing was observed previously for complementary 
combinations with trinucleotides GCC and UAC at positions 9-11 (Table 1, Chapter 2).  
In contrast, only 20% of the protein knockdown that results from complementary siRNAs 
with atypical activity, those with trinucleotides UUC, UCU, and UCG at positions 9-11, 
can be attributed to mRNA degradation.  The majority of the protein knockdown for these 
combinations is due to translational repression.  These results seem to be independent 
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of whether the reporter is expressed transiently or stably.  This unusual activity is not 
due to the particular siRNAs used in these experiments as the same siRNAs generate 
similar degrees of RNA and protein knockdowns when targeted to sequences with two or 
more mismatches in positions 9-11.  In addition, this phenomenon has been observed 
with three different mRNA:siRNA complementary combinations, those with trinucleotides 
UUC, UCU and UCG at positions 9-11.  Large screens have previously been conducted 
to identify features that lead to effective siRNA knockdown (Khvorova et al., 2003; 
Reynolds et al., 2004; Schwarz et al., 2003; Taxman et al., 2006).  Generally, siRNA 
efficiency has been evaluated by measuring either the extent of RNA knockdown or 
target protein knockdown, but rarely both.  Therefore, it is possible that perfectly 
complementary combinations that result in silencing primarily through translational 
repression were missed in these large siRNA libraries. 
The observation that complementary combinations can result in translational 
repression was previously noted in hippocampal neurons (Davidson et al., 2004).  
siRNAs targeting SOD1 or caspase-3 mRNAs resulted in downregulation of the 
respective protein within 6 hours after transfection.  However, only one of the four 
complementary siRNAs tested, yielded mRNA downregulation, albeit 24 hours after 
transfection (Davidson et al., 2004).  The complementary combinations that did not yield 
mRNA degradation had a CUA or an AGA trinucleotide sequence at positions 9-11.  The 
combination that resulted in both RNA and protein knockdown had a GGU trinucleotide 
sequence at positions 9-11.  None of these trinucleotide sequences at positions 9-11 are 
represented in our study (Davidson et al., 2004).  However, it is possible that the 
observations made with complementary combinations in neurons and our own 
observations with atypical complementary combinations share a common mechanism. 
In addition to an increase in protein/RNA knockdown ratios, complementary 
combinations with atypical protein/RNA knockdown ratios seem to result in enhanced 
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protein silencing as compared to other complementary combinations which are 
associated with the same degree of protein and RNA knockdown (Combinations 13 and 
27; Table 1, Chapter 2).  For example, transient expression of complementary 
combinations with a UAC and a GCC trinucleotide sequence at positions 9-11 in AGO2 
knockout MEFs transfected with an Ago2 containing plasmid, resulted in 19.3 + 6.5 and 
11.6 + 1.0 -fold protein changes, respectively.  In contrast, the comparable transfection 
of the complementary combination with a UCU trinucleotide at positions 9-11 resulted in 
28.7 + 3.1-fold protein change.  Studies in which a large number of siRNAs were used 
against a common target have identified several determinants that correlate with 
increased siRNA-mediated silencing (Khvorova et al., 2003, Reynolds, 2004 #77).  
Among these determinants, low internal stability (positions 9-14) (Khvorova et al., 2003) 
and an A or U at position 10 (Reynolds et al., 2004) are both associated with increased 
siRNA efficiency.  Neither of these two parameters can account for the increased 
silencing efficiency we observed for complementary siRNAs with atypical protein/RNA 
knockdown ratios.  For example, a change from the trinucleotide sequence UAC to UUC 
at positions 9-11 caused the protein/RNA knockdown ratio to increase from 1 to 5.  This 
single nucleotide change would not affect significantly the internal stability of the 
mRNA:siRNA duplex or change the preference of an A or a U at position 10.  In addition 
to sequence determinants, local mRNA secondary structure and target accessibility are 
also thought to be important for siRNA and miRNA efficiency (Ameres et al., 2007; 
Cullen, 2006; Heale et al., 2005; Long et al., 2007; Luo and Chang, 2004; Overhoff et 
al., 2005; Schubert et al., 2005).  However, in all of the cases reported in our study, the 
only changes made to the RNA reporter were within positions 9-11 and are not likely to 
affect the reporter’s mRNA secondary structure. 
Determinants that correlate with miRNA efficiency have also been identified.  
These include base pairing at position 8, an A at position 1 on the target mRNA, an A or 
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U at position 9 on the target mRNA, proximity between binding sites, A/U rich sequences 
surrounding binding sites, additional 3' complementarity, number of binding sites, and 
proximity of binding sites to the end of the coding sequence or the end of the 3' UTR 
(Doench and Sharp, 2004; Grimson et al., 2007; Nielsen et al., 2007).  It is unknown if all 
of these determinants correlate with translational repression alone and not with both an 
increase in miRNA-mediated RNA and protein knockdown.  Additionally, with the 
exception of the A or U at position 9 determinant, none of these determinants apply to 
the atypical complementary combinations described in this chapter given that the only 
variable that changed for these combinations was the sequence of positions 9-11.  
Having an A or a U at position 9 did not correlate with atypical protein/RNA knockdown 
ratios since reporters with a UUC or a UCG trinucleotide sequence at positions 9-11 
were in this group. 
Our results indicate that the dramatic silencing observed with atypical 
complementary combinations is sequence-specific and dependent on Ago2.  
Furthermore, enhanced silencing and high protein/RNA knockdown ratios are no longer 
observed when one of the catalytic residues within Ago2 is mutated, indicating that these 
effects are dependent on Ago2-mediated catalysis.  Given the extent of RNA knockdown 
and the disparity observed between protein and RNA knockdown for atypical 
complementary combinations, we postulate that endonucleolytic cleavage is not 
important for the actual silencing step.  In fact, stable expression of reporters with 
atypical complementary protein/RNA knockdown ratios, resulted in small RNA changes 
(2.0 + 0.6 and 0.91 + 0.1-fold for both reporters with a UCU and a UUC trinucleotide 
sequence at positions 9-11).  Compared to the RNA knockdown observed for stable 
transfections of typical perfect combinations, the equivalent extent of RNA knockdown 
for combinations with atypical protein/RNA knockdown ratios was only observed when 
the atypical combinations were transiently transfected.  In addition, if typical and atypical 
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complementary combinations are compared using the same type of experimental 
protocol (transient transfection), complementary combinations with typical protein/RNA 
knockdown ratios always result in a higher extent of RNA knockdown.  For example, 
transient expression of complementary combinations with a GCC trinucleotide sequence 
at positions 9-11 in AGO2 knockout MEFs transfected with an Ago2 containing plasmid, 
resulted in 12.6 + 0.1 -fold mRNA changes while transfection of the complementary 
combination with a UCU trinucleotide at positions 9-11 resulted in 6.4 + 0.2 -fold mRNA 
change. 
Given that endonucleolytic cleavage does not seem to be as important for the 
silencing of complementary combinations with atypical protein/RNA knockdown ratios, it 
is possible that cleavage is instead required for an event upstream of the actual silencing 
mechanism.  In Drosophila, siRNAs and miRNAs partition into distinct Argonaute 
complexes (Forstemann et al., 2007; Tomari et al., 2007).  siRNAs bind to Ago2 
whereas miRNAs preferentially bind to Ago1 containing complexes.  In Drosophila, 
partitioning of small RNA duplexes is dependent on the structure of the duplex and not 
dependent on which of the two Dicer enzymes processes the precursor duplex.  For 
example, pre-miRNA duplexes, which in Drosophila are processed by Dicer-1, will 
associate with Ago2 containing miRNPs if the miRNA duplex is perfectly complementary 
(Forstemann et al., 2007).   
Small RNA partitioning can have phenotypic consequences, because Drosophila 
Ago1 is a poor endonuclease and does not induce robust silencing of perfectly matched 
targets, whereas Drosophila Ago2 does not direct degradation and robust silencing of 
mRNAs with central mismatches in their target sites (Forstemann et al., 2007).  In 
addition, the mechanism of strand selection for a siRNA or miRNA duplex is determined 
both by the specific Argonaute protein to which they bind and by the structure of the 
mature duplex (Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand 
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et al., 2005).  In both Drosophila embryos and human cell extracts, Ago2 containing 
RISCs can cleave the passenger strand of a siRNA duplex or the miRNA* strand of a 
miRNA/miRNA* duplex designed to have perfect complementarity (Leuschner et al., 
2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 2005).  Introduction of a 
chemical modification in the scissile phosphodiester bond (position 10) of the miRNA* 
strand that blocks Ago2-catalyzed cleavage, inhibits Ago2 loading of mammalian miR-1 
and reduces silencing of its target when the miR-1 strand is perfectly matched to its miR-
1* strand.  However, there is no effect on miR-1 loading and silencing when the miR-
1/miR-1* duplex contains central mismatches (Matranga et al., 2005).  This indicates 
that endogenous animal miRNAs, which are processed from mismatched pre-miRNA 
duplexes, can be loaded into Ago2 by a bypass mechanism that does not require 
cleavage (Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et 
al., 2005).  In addition, these results also indicate that siRNA loading and siRNA-
mediated silencing are facilitated by Ago2 cleavage.  In mammals, it appears that all four 
Argonautes are capable of binding miRNAs (Meister et al., 2004) and at least Ago1, 
Ago2 and Ago3 are able to bind siRNAs in vivo as well (Liu et al., 2004), indicating that 
small RNA partitioning might not occur as described in Drosophila (Bellare and 
Sontheimer, 2007).  However, as suggested by the in vitro studies (Meister et al., 2004), 
it is possible that cleavage-assisted loading of siRNAs by Ago2 provides some level of 
specificity to the function of Ago2 containing RISC complexes (Matranga and Zamore, 
2007).  This hypothesis could explain why the effects of complementary combinations 
with atypical protein/RNA knockdown ratios are dependent on Ago2-mediated catalysis.  
Perhaps, Ago2 assisted cleavage of atypical complementary siRNAs is necessary for 
proper loading and RISC function in our experiments.  
If catalysis is necessary for proper loading into Ago2 containing RISC, how can 
the difference between the RNA and protein knockdown observed for atypical 
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complementary combinations be explained?  The disparity between the RNA and protein 
knockdown for complementary combinations with UUC, UCU and UCG trinucleotides at 
positions 9-11 suggests that Ago2-mediated cleavage is not the primary mode of 
silencing.  The differences between RNA and protein knockdown between typical versus 
atypical complementary combinations could reflect a substrate preference for RISC 
cleavage.  It is possible that these atypical complementary combinations result in 
sustained RISC binding, but inefficient cleavage.  One could test this hypothesis by 
transfecting a reporter RNA containing a chemical modification at position 10 and/or 11, 
such as a phosphorothioate modification or a 2'-O-methylated base, to prevent Ago2-
mediated target cleavage.  If inhibiting cleavage of the modified target leads to enhance 
binding, then we would expect that the noncleavable reporter RNA would be silenced 
primarily through translational repression.  An alternatively explanation for why Ago2-
mediated cleavage is necessary but does not contribute to the primary mode of silencing 
for atypical complementary combinations is that Ago2 is required for strand selection 
and loading, while other Argonautes, which do not posses catalytic activity, are 
responsible for the actual silencing step.  
We have proposed a model in which complementary siRNAs that result in 
atypical protein/RNA knockdown ratios and enhanced silencing are properly loaded into 
RISC complexes by Ago2-mediated catalysis.  However, our model also proposes that 
enhanced silencing is due likely to inefficient RISC cleavage.  These two hypotheses 
result in the following conundrum: how are atypical siRNAs loaded if Ago2 cleavage is 
required but yet inefficient cleavage is a characteristic of their silencing activity?  It is 
important to note that these atypical combinations still result in some degree of target 
RNA knockdown, albeit substantially lower than for perfect complementary 
combinations. Perhaps, inefficient Ago2-mediated cleavage produces a sufficient 
number of siRNA loaded RISC to mediate target silencing.   
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Our results indicate that Ago2-mediated cleavage might have sequence 
preferences.  The ultimate biological significance of this specificity remains to be 
elucidated.  Future experiments that address the significance of this phenomenon will 
shed light on regulatory mechanisms important for Ago2 function and RNAi biology.  
Materials and Methods 
DNA constructs 
EGFP control plasmid, wild type human Ago1 and Ago2 constructs we obtained from the 
Tuschl lab (Meister et al., 2004).  Briefly, EGFP and Ago constructs containing a N-
terminal FLAG/HA tag were cloned into a modified pIRESneo plasmid (Meister et al., 
2004).  Ago2 D597A was made using Quick Change and the following oligos: Ago2 
D597A forward primer 5' - TTTCTGGGAGCAGCCGTCACTCACCCC - 3'; Ago2 D597A 
reverse primer 5'- GGGGTGAGTGACGGCTGCTCCCAGAAA - 3'.  The firefly 
expressing reporter GL3 (Promega) was used for transient transfections to control for 
transfection efficiency.   
Construction of targeted reporter constructs and stable cell lines  
A modified version of the pRL-TK vector containing a multiple-cloning site downstream 
of the Renilla luciferase stop codon was previously generated (pRL-TK 3'MCS, see 
Materials and Methods section in Chapter 2).  To create constructs that could be 
transiently transfected and used for creating stable cell lines, a pRL-TK 3'MCS Bgl 
II/HpaI fragment containing the Renilla luciferase gene and the SV40 poly A signal was 
cloned into a pPur BamHI/SwaI fragment containing the puromycin resistance gene 
(pRL-TK 3'MCS Pur).  3' UTR binding sites were constructed by annealing two DNA 
oligonucleotides containing two identical CXCR4 binding sites separated by the 
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sequence CCGG and flanked by XhoI and SpeI sites.  Annealed oligos were then 
inserted into pRL-TK 3'MCS Puro’s XhoI and SpeI sites, which are located directly 
downstream from the Renilla luciferase coding region.  To create a stably expressing cell 
line of these Renilla reporters, HeLa cells were transfected with the pRL-TK 3'MCS Puro 
vector containing CXCR4 binding sites and selected with puromycin (600 ng/mL). 
siRNAs 
siRNAs were purchased from Dharmacon and prepared according to manufacturer’s 
instructions.  Sequences of siRNAs (sense strand) used in this study are as follows:  
siControl (ON-TARGETplus siCONTROL, Dharmacon):  
5’- UGGUUUACAUGUCGACUAA -3'; 
GFP: 5'- GGCUACGUCCAGGAGCGCAdTdT -3';  
CXCR4: 5'- GUUUUCACUCCAGCUAACAdTdT -3';  
CXCR4-B: 5'- GUUUUCACGCCAGCUAACAdTdT -3';  
CXCR4-C: 5'- GUUUUCACUCGAGCUAACAdTdT -3';  
CXCR4-D: 5'- GUUUUCACUACAGCUAACAdTdT -3'; 
CXCR4-E: 5'- GUUUUCACUCUAGCUAACAdTdT -3'; 
CXCR4-F: 5'- GUUUUCACUUCAGCUAACAdTdT -3'; 
CXCR4-G: 5'- GUUUUCACUCAAGCUAACAdTdT -3'; 
CXCR4-t9C near perfect: 5'- GUUUUCACAUGAGCUAACAdTdT -3'; 
CXCR4-t9G: 5'- CGGAGGGAAUCAGCUAACAdTdT -3'; 
CXCR4-t9C: 5'- CGGAGGGAAUGAGCUAACAdTdT -3'; 
CXCR4-t9U: 5'- CGGAGGGAAUAAGCUAACAdTdT -3'; 
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Cell culture and transfections 
HeLa cells or AGO2 -/- MEFs obtained from the Hannon lab (Liu et al., 2004) were 
grown in DMEM supplemented with 10% inactivated fetal bovine serum and 
penicillin/streptomycin.  For stable cell line transfections, the day before transfection, 
cells were seeded at 1.5X105 cells/well for 6-well plates and 3.0X104 cells/well for 24-
well plates in antibiotic-free media.  Transfections were performed using Oligofectamine 
according to the manufacturer’s instructions (Invitrogen) in a final volume of 1.25 mL for 
6-well plates and 0.25 mL for 24-well plates.  For transient cell line transfections, the day 
before transfection, cells were seeded at 5.5X105 cells/well for 6-well plates and 1.0X105 
cells/well for 24-well plates in antibiotic-free media.  Transfections were performed using 
Lipofectamine 2000 according to the manufacturer’s instructions (Invitrogen) in a final 
volume of 2.50 mL for 6-well plates and 0.50 mL for 24-well plates.  For transient HeLa 
cell transfections, Renilla reporter constructs were transfected at a final concentration of 
1.5 ng/µl and the firefly reporter construct (GL3, Promega) was transfected at a final 
concentration of 0.1 ng/µl.  For the transient AGO2 -/- MEFs’ transfections, the Renilla 
reporter with a UCU trinucleotide at position 9-11 was transfected at a final concentration 
of 1.1 ng/µl, the firefly reporter construct (GL3, Progema) was transfected at a final 
concentration of 0.1 ng/µl, and the EFGP control vector, Ago2 or Ago1 containing 
plasmids were transfected at a final concentration of 0.4 ng/µl.  For both transient and 
stable transfections siRNAs were used at a final concentration of 10 nM.   
Real time RT-PCR 
For detection of Renilla mRNA, total RNA was harvested 48 hrs after transfection 
(unless otherwise indicated) using the RNAeasy kit (Qiagen) and DNAse-treated with 
Turbo DNAse (Ambion).  5 µg or 500 ng of DNAse treated RNA were used for reverse 
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transcription reactions with specific primers for Renilla luciferase (Rluc) and TATA 
binding protein (TBP), which served as an internal control.  The following are the reverse 
transcription primers for TBP and Rluc: TBP RT primer 5'-
GTACATGAGAGCCATTACGTCGTC-3'; Rluc RT primer 5'-
GCATTCTAGTTGTGGTTTGTCC-3'.  The Rluc RT primer is located downstream of the 
3' UTR CXCR4 binding sites.  Reverse transcription was performed using Superscript III 
(Invitrogen) according to manufacturer’s guidelines.  1 µl of reverse transcription reaction 
was subjected to real-time PCR.  Each PCR reaction was measured in quadruplicate.  
Rluc primers and probe were designed against the cDNA junction between pRL-TK 
vector sequence and the Renilla luciferase exon (pRL-TK contains a chimeric intron 
upstream of the Renilla reporter gene).  The following are the primers and Taqman 
probes used for amplification of Rluc and TBP: Rluc forward primer (FP) 5'-
TGCAGAAGTTGGTCGTGAGGCA-3'; Rluc reverse primer (RP) 5'-
TCTAGCCTTAAGAGCTGTAATTGAACTGGG-3'; Rluc probe 5’-FAM-
TGGGCAGGTGTCCAC-MGB-NFQ-3' (FAM: 6-carboxy-fluorescin; MGB: minor groove 
binding; NFQ: nonfluorescent quencher; Applied Biosystems); TBP primers and probe 
were obtained from Applied Biosystems (Taqman Gene Expression Assays, # 
Hs00427620_m1).  Real-time PCR was performed in a total volume of 25 µl, using the 
Taqman Universal PCR Master Mix protocol according to manufacturer’s instructions.  
Final concentrations of probes and primers used per reaction were 250 nM and 900 nM, 
respectively.  Relative mRNA levels were determined using the 2-∆∆Ct method.  mRNA 
amounts were normalized to a GFP siRNA or a siControl siRNA (Dharmacon) 
transfection.  
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Luciferase assays 
Renilla luciferase assays or dual-luciferase assays were performed 48 hours after 
transfection (unless indicated otherwise) according to manufacturer’s instructions 
(Promega) and detected with a Glomax 20/20 luminometer (Promega).  Each 
transfection reaction and luciferase assay was done in triplicate.  All of the readings 
obtained from luciferase assays were within the linear range (seven orders of 
magnitude) established by both the manufacturer (Promega) and by titration 
experiments previously performed in our lab.  For Renilla luciferase assays, Renilla 
luciferase activity was assayed and normalized to a GFP siRNA or a siControl siRNA 
(Dharmacon) transfection.  For dual luciferase assays, Renilla and firefly luciferase 
activities were consecutively assayed.  Renilla luciferase readings were first normalized 
to firefly luciferase readings.  Relative Renilla luciferase counts were then normalized 
against a GFP or a siControl siRNA (Dharmacon) transfection.  
siRNA degradation analysis 
siRNAs were 5' labeled in reactions containing 10 pmol of siRNA,  γ-32P-ATP 
(6000 Ci, mmol, New England Nuclear), 1 unit of T4 polynucleotide kinase (New 
England Biolabs), and 1 µl of 1X T4 polynucleotide kinase buffer (New England Biolabs) 
in a final volume of 10 µl.  The reaction was incubated for 30 minutes at 37 ˚C.  
Radiolabeled siRNAs were purified using Sephadex G25 columns (GE Healthcare).  
Samples were heated for 5 minutes at 90 ˚C and separated on a 15% denaturing 
polyacrylamide gel.  A radioactively labeled 10 base pair DNA ladder (Invitrogen) was 
used as a length standard.  The gel was exposed on a phosphoimager screen for 2 
hours and analyzed using Image Quant Software.  For each siRNA tested, intact siRNA 
signal was compared to the sum of the signals obtained from all of the degradation 
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products. 
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 Figures 
 
Figure 3.1 - Time course experiment of G:U wobble at position 9.   
RNA and protein reductions of a Renilla reporter with a UCU trinucleotide at positions 9-11 that 
was either (A) stably expressed or (B) transiently transfected in HeLa cells.  Cells were 
transfected with either 10 nM of a siRNA that results in a G:U wobble at position 9, CXCR4 
(combination 6, G:U) or 10 nM of a siRNA that results in a bulge within positions 9-11, CXCR4-
t9C near perfect (Bulge).  Cells were collected for RNA and protein analysis 24 and 48 hours 
after transfection.  Samples were normalized to an unrelated siRNA (targeting GFP).  Normalized 
average mRNA and protein knockdown (fold change + SD) are shown.  mRNA sequences (black) 
and guide siRNA sequences (red) for positions 9-11 are shown underneath relevant combinations. 
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Figure 3.2 - RNA and protein effects for a G:U wobble combination compared to 
those of related mRNA:siRNA duplexes.   
HeLa cells were transiently transfected with three different Renilla reporter constructs which only 
differed at position 9.  Cells were transfected with either 10 nM of a siRNA that results in a G:U 
wobble or a mismatch at position 9, CXCR4, or 10 nM of a siRNA that results in at least 2 
mismatches within positions 9-11, CXCR4-t9C near perfect (Mismatch).  Cells were collected for 
RNA and protein analysis 48 hours after transfection.  Samples were normalized to an unrelated 
siRNA (Control).  Normalized average mRNA and protein knockdown (fold change + SD) were 
calculated from two independent experiments.  mRNA sequences (black) and guide siRNA 
sequences (red) for positions 9-11 are shown underneath relevant combinations. 
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Figure 3.3 - Perfectly complementary siRNAs can result in translational repression 
and enhanced silencing. 
HeLa cells were transiently transfected with two different Renilla reporter constructs which only 
differed in sequence at position 9.  When the appropriate siRNAs are transfected, both of these 
reporters can form G:U wobbles at position 9 with different symmetries.  Cells were transfected 
with four different siRNAs: I) 10 nM of a perfectly complementary siRNA, CXCR4-E and 
CXCR4-C for the reporter with a U and a G at position 9, respectively (Perf); II) 10 nM of a 
siRNA that results in a G:U wobble at position 9,  CXCR4 and CXCR4-G for the reporter with a 
U and a G at position 9, respectively (Wobble); III) 10 nM of a siRNA that results in a G:U 
wobble at position 9 with no complementarity from positions 10-19, CXCR4-t9G and CXCR4-
t9U for the reporter with a U and a G at position 9, respectively (Wobble w/out 3' comp); IV) or 
10 nM of a siRNA that results in a bulge within positions 9-11, CXCR4-t9C near perfect and 
CXCR4-B for the reporter with a U and a G at position 9, respectively (Bulge).  Cells were 
collected for RNA and protein analysis 48 hours after transfection.  Samples were normalized to 
an unrelated siRNA (Control).  Normalized average mRNA and protein knockdown (fold change 
+ SD) were calculated from two independent experiments.  mRNA sequences (black) and guide 
siRNA sequences (red) for positions 9-11 are shown underneath relevant combinations. 
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Figure 3.4 - Perfectly complementary siRNAs can result in high protein/RNA 
knockdown ratios in both cell line and transient transfections. 
RNA and protein reductions of a Renilla reporter with a UCU or a UUC trinucleotide sequence at 
positions 9-11 that was either stably expressed (A, B) or transiently transfected (C)  in HeLa 
cells.  Cells were transfected with either I) 10 nM of a perfectly complementary siRNA, CXCR4-
E and CXCR4-F for the UCU and the UUC reporter, respectively (Perf); II) 10 nM of a siRNA 
that results in a G:U wobble at position 9 or 10, CXCR4 for both UCU and UUC reporters (G:U); 
III) 10 nM of a siRNA that results in a G:U wobble at position 9 or 10 with a mismatch at 
position 11, CXCR-B for both UCU and UUC reporters (G:U w/ mis); IV) or 10 nM of a siRNA 
that results in a bulge within positions 9-11, CXCR4-t9C near perfect and CXCR4-B for the UCU 
and the UUC reporter, respectively (Bulge).  Cells were collected for RNA and protein analysis 
48 hours after transfection.  Samples were normalized to an unrelated siRNA (Control).  
Normalized average mRNA and protein knockdown (fold change + SD) are shown. mRNA 
sequences (black) and guide siRNA sequences (red) for positions 9-11 are shown underneath 
relevant combinations. 
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Figure 3.5 - Dramatic silencing resulting from atypical siRNAs is not an 
experimental artifact. 
(A) HeLa cells were transiently transfected with a reporter containing a UCU or a UUC 
trinucleotide sequence at positions 9-11 and 10 nM of their respective perfectly complementary 
siRNAs, CXCR4-E and CXCR4-F for the UCU and the UUC reporter, respectively (Perf).  
Perfectly complementary siRNAs were re-synthesized and newly made aliquots were used for 
this experiment.  Cells were collected for RNA and protein analysis 48 hours after transfection.  
Samples were normalized to an unrelated siRNA (Control).  Normalized average mRNA and 
protein knockdown (fold change + SD) are shown.  mRNA sequences (black) and guide siRNA 
sequences (red) for positions 9-11 are shown underneath relevant combinations.  (B) Different 
preparations (indicated by #1 and #2) of  siRNAs that result in typical complementary 
combinations (CXCR4-B and CXCR4-D), siRNAs that result in atypical complementary 
combinations (CXCR4-C and CXCR4-E) as well as a siRNA that results in a G:U wobble at 
position 9 (CXCR4) and an unrelated siRNA (Control) were 5' end labeled and resolved in a 15% 
polyacrylamide denaturing gel.  mRNA sequences (black) and antisense siRNA sequences (red) 
for positions 9-11 are shown above each siRNA labeled to indicate the pertinent combinations.  
Protein/RNA knockdown ratios (blue) are indicated for the combinations that these siRNAs 
generated.  (C) Quantification of (B).  Percentages of intact and degraded siRNAs were 
calculated by dividing the total radioactive siRNA signal by the specific radioactive signal from 
intact siRNA or the sum of the radioactive signals from degradation products, respectively. 
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Figure 3.6 - The dramatic silencing effect resulting from atypical perfect siRNAs is 
dependent on Ago2 function. 
RNA and protein analysis of a Renilla luciferase reporter with a UCU trinucleotide sequence at 
positions 9-11, after transfection in AGO2 -/- MEFs with either I) 10 nM of a perfectly 
complementary siRNA, CXCR4-E (Perf); II) 10 nM of a siRNA that results in a G:U wobble at 
position 9, CXCR4 (G:U); III) or 10 nM of a siRNA that results in a G:U wobble at position 9 
with a mismatch at position 11, CXCR4-B (G:U w/ mis).  Reporters were co-transfected with 
either a control EGFP plasmid (Control), an Ago2 (AGO2) or an Ago1 (AGO1) expressing 
plasmid.  Samples were normalized to an unrelated siRNA transfection (Control).  Normalized 
average mRNA and protein knockdown (fold change + S.D.) were calculated from two 
independent experiments.  mRNA sequences (black) and guide siRNA sequences (red) for 
positions 9-11 are shown underneath relevant combinations. 
  
Chapter 3: Characterization of mRNA:siRNA combinations with high protein/RNA knockdown ratios 
 110 
 
 
Figure 3.7 - Ago2’s catalytic activity is necessary for full silencing effects 
exhibited by atypical perfect siRNAs. 
RNA and protein analysis of a Renilla luciferase reporter with a UCU trinucleotide sequence at 
positions 9-11, after transfection in AGO2 -/- MEFs with either 10 nM of a perfectly 
complementary siRNA, CXCR4-E (Perf), 10 nM of a siRNA that results in a G:U wobble at 
position 9, CXCR4 (G:U) or 10 nM of a siRNA that results in a G:U wobble at position 9 with a 
mismatch at position 11, CXCR4-B (G:U w/ mis).  Reporters were co-transfected with either a 
control EGFP plasmid (Control), a wild type Ago2 (AGO2) or catalytically dead Ago2 (AGO2 
D597A) expressing plasmid.  Samples were normalized to an unrelated siRNA transfection 
(Control).  Normalized average mRNA and protein knockdown (fold change + S.D.) were 
calculated from three independent experiments. mRNA sequences (black) and guide siRNA 
sequences (red) for positions 9-11 are shown underneath relevant combinations.
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siRNAs have been shown to be mediators of the RNAi response.  When 
complementary to their targets, they are able to guide endonucleolytic cleavage, 
resulting in mRNA downregulation.  The specificity of siRNA-mediated silencing has 
been intensely investigated given the widespread experimental use of siRNAs and their 
potential therapeutic applications.  Off-target effects have been previously defined as the 
downregulation of transcripts levels after transfection of an unrelated siRNA (Jackson et 
al., 2003).  However, the consequences of off-target effects at the protein level were 
poorly understood. 
The work described in this dissertation has primarily focused on whether 
interactions between partially complementary siRNA guide strands and mRNAs produce 
tightly correlated changes in mRNA and protein downregulation.  In particular, we have 
investigated the importance of the central region of the mRNA:siRNA duplex, positions 
9-11, because this region is directly involved in siRNA-mediated target transcript 
cleavage.  
Using a reporter system with binding sites to a siRNA we have determined the 
extent of RNA and protein knockdown for a large panel of mismatched mRNA:siRNA 
duplexes within positions 9-11.  As discussed in Chapter 2, RNA analysis of these 
combinations confirmed that partial complementarily can result in mRNA downregulation 
even when the mismatches are within the positions involved in siRNA-mediated target 
cleavage.  In addition, comparison of RNA and protein knockdown for the 30 
mRNA:siRNA combinations showed that in addition to mRNA downregulation, off-target 
effects can result in translational repression.  These results underscore the importance 
of measuring both RNA and protein downregulation when assessing the full impact of 
off-target effects.  
Given the similarities between miRNA silencing and off-target effects, the results 
described in Chapter 2 may have implications for miRNA-mediated silencing pathways.  
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Experiments aimed at elucidating the mechanisms by which imperfectly complementary 
siRNAs mediate transcript downregulation, revealed that Ago2 is not required for off-
target mRNA downregulation.  Drosophila Ago1 (the Argonaute protein in Drosophila 
dedicated to the miRNA pathway) is required for miRNA-mediated target degradation 
(Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu et al., 2006), however, it is 
currently not known which of the four human Argonautes mediates target degradation.  
Our results suggest that Ago2 is not necessary for miRNA-mediated transcript 
downregulation in human cells.   
Given that miRNAs are known to reduce mRNA levels by inducing rapid 
deadenylation (Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu et al., 2006), it is 
also likely that off-target interactions result in rapid deadenylation.  Future experiments 
will test this hypothesis by determining the poly A tail length of a reporter in the presence 
of a complementary or a mismatched siRNA.  Poly A tail length should also be 
determined for complementary and mismatched combinations in the absence of Ago2.  
As noted in Chapter 2, in the absence of Ago2 expression, two of the complementary 
combinations (combinations 13 and 27) resulted in a large disparity between RNA and 
protein knockdown, similar to the results observed for imperfectly complementary 
combinations.  This finding indicates that in the absence of Ago2 expression, 
complementary combinations can enter an alternative pathway to endonucleolytic 
cleavage, perhaps through increased deadenylation.  The additional experiments 
proposed will provide a better mechanistic understanding of off-target mRNA 
downregulation in human cells.  
In addition to uncovering mismatched combinations that result in mRNA and 
protein knockdown that are independent of Ago2 function, we have also identified 
complementary combinations that result in high protein/RNA knockdown ratios.  How 
these complementary siRNAs result in atypical protein/RNA knockdown ratios remains 
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unclear.  Unlike the mismatched combinations with unequal RNA and protein 
knockdowns described in Chapter 2,  RNA and protein knockdowns for atypical 
complementary combinations are dependent on Ago2’s catalytic activity.  Given that 
endonucleolytic cleavage is not the primary mechanism responsible for overall protein 
silencing for these combinations, it is likely that Ago2’s catalytic activity is required for 
passenger strand cleavage and strand selection of these atypical complementary 
siRNAs.  Therefore, we hypothesize that complementary combinations with atypical 
protein/RNA knockdown ratios may not be cleaved efficiently and that inefficient 
cleavage leads to sustained binding and translational repression.  
The results described in Chapter 3 leave a number of questions unanswered. 
Future experiments should focus on the following questions.  First, can complementary 
combinations placed in different mRNA contexts and sequences result in high 
protein/RNA knockdown ratios?  Second, do high protein/RNA knockdown ratios for 
atypical complementary combinations depend on the location of the siRNA binding site  
(e.g. 3' UTR versus coding region)?  Third, do the high protein/RNA knockdown ratios for 
atypical complementary combinations change with the number of siRNA binding sites?  
Answering these questions will lead to a better understanding of the mechanisms that 
are involved in small RNA silencing. 
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• Participated in the development and implementation of a survey tool for MIT Biology 
graduate students to provide feedback on the graduate school curriculum.  
• Organized meeting for minority graduate students to elicit input regarding minority 
recruitment and retention in the Biology Department at MIT.  
 
03/2007, 03/2005 Graduate Student Representative: External Visiting Committee, Department of Biology, 
Massachusetts Institute of Technology, Cambridge, MA. 
 
01/2002 Co-organizer of a Prospective Graduate Student Visit: Department of Biology, 
Massachusetts Institute of Technology, Cambridge, MA.  
• Coordinated and organized activities for 40 prospective graduate students during a 
recruitment weekend. 
 
AWARDS & HONORS 
 
2007-present National Science Foundation Graduate Research Fellowship 
 
2003-2007 NIH National Research Service Award (NRSA) Pre-doctoral Fellowship 
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2001-2002 Leventhal Presidential Fellow (MIT) 
 
1998  Brown University Undergraduate Teaching and Research Assistantship Award  
 
1997  American Cancer Society Summer Research Assistant Fellowship Award 
 
MEETINGS & PRESENTATIONS 
 
01/2007   Poster Presentation: “Comparison of siRNA-induced off-target RNA and protein effects”,  
  RNAi for Target Validation, Keystone Symposia Conference, Keystone, CO. 
 
09/2005  Oral Presentation: “Specificity of the mRNA:siRNA interaction in gene silencing”, Cold  
  Spring Harbor RNAi Meeting, Cold Spring Harbor, NY. 
 
07/1998 Poster Presentation: “DNA Replication in Sciara coprophila”, Undergraduate Teaching 
and Research Assistantship Symposium, Brown University, Providence, RI. 
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